| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 5.51e-25 | 46 | 45 | 13 | GO:0030020 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 COL1A2 | 1.02e-21 | 188 | 45 | 16 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 KRT5 COL6A2 KRT6A KRT6B COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 KRT6C COL1A2 | 8.75e-16 | 891 | 45 | 20 | GO:0005198 |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 2.60e-06 | 43 | 45 | 4 | GO:0030280 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 3.23e-04 | 12 | 45 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 3.23e-04 | 12 | 45 | 2 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 4.44e-04 | 14 | 45 | 2 | GO:0097493 | |
| GeneOntologyMolecularFunction | integrin binding | 6.42e-04 | 175 | 45 | 4 | GO:0005178 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 3.13e-03 | 130 | 45 | 3 | GO:0005200 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL7A1 COL8A1 ELN COL11A2 COL13A1 COL1A2 | 6.44e-13 | 377 | 44 | 13 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL7A1 COL8A1 ELN COL11A2 COL13A1 COL1A2 | 6.66e-13 | 378 | 44 | 13 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL7A1 COL8A1 ELN COL11A2 COL13A1 COL1A2 | 6.88e-13 | 379 | 44 | 13 | GO:0045229 |
| GeneOntologyBiologicalProcess | collagen-activated tyrosine kinase receptor signaling pathway | 8.80e-09 | 12 | 44 | 4 | GO:0038063 | |
| GeneOntologyBiologicalProcess | collagen-activated signaling pathway | 5.39e-08 | 18 | 44 | 4 | GO:0038065 | |
| GeneOntologyBiologicalProcess | skin development | 1.07e-06 | 373 | 44 | 8 | GO:0043588 | |
| GeneOntologyBiologicalProcess | epidermis development | 5.13e-06 | 461 | 44 | 8 | GO:0008544 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 1.96e-05 | 75 | 44 | 4 | GO:0045109 | |
| GeneOntologyBiologicalProcess | epidermal cell differentiation | 2.94e-05 | 284 | 44 | 6 | GO:0009913 | |
| GeneOntologyBiologicalProcess | nephron development | 3.36e-05 | 174 | 44 | 5 | GO:0072006 | |
| GeneOntologyBiologicalProcess | keratinization | 3.52e-05 | 87 | 44 | 4 | GO:0031424 | |
| GeneOntologyBiologicalProcess | keratinocyte differentiation | 4.98e-05 | 189 | 44 | 5 | GO:0030216 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | LAMA5 COL5A1 COL8A1 ELN COL11A2 BCL11B FBN2 COL13A1 MAGED1 SSUH2 COL1A2 | 5.33e-05 | 1269 | 44 | 11 | GO:0009887 |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 5.85e-05 | 99 | 44 | 4 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 6.08e-05 | 100 | 44 | 4 | GO:0045103 | |
| GeneOntologyBiologicalProcess | epithelium development | FKBPL LAMA5 COL5A1 KRT5 KRT6A KRT6B BCL11B MAGED1 ITGA5 OVOL3 KRT6C | 1.97e-04 | 1469 | 44 | 11 | GO:0060429 |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 1.98e-04 | 10 | 44 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | odontogenesis | 2.98e-04 | 151 | 44 | 4 | GO:0042476 | |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | 3.09e-04 | 619 | 44 | 7 | GO:0002009 | |
| GeneOntologyBiologicalProcess | collagen fibril organization | 5.71e-04 | 76 | 44 | 3 | GO:0030199 | |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | 8.35e-04 | 957 | 44 | 8 | GO:0097435 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | 9.69e-04 | 750 | 44 | 7 | GO:0048729 | |
| GeneOntologyBiologicalProcess | kidney development | 1.13e-03 | 372 | 44 | 5 | GO:0001822 | |
| GeneOntologyBiologicalProcess | renal system development | 1.33e-03 | 386 | 44 | 5 | GO:0072001 | |
| GeneOntologyBiologicalProcess | wound healing, spreading of epidermal cells | 1.62e-03 | 28 | 44 | 2 | GO:0035313 | |
| GeneOntologyCellularComponent | complex of collagen trimers | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 COL11A2 COL1A2 | 1.97e-22 | 21 | 44 | 10 | GO:0098644 |
| GeneOntologyCellularComponent | collagen trimer | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 2.41e-21 | 88 | 44 | 13 | GO:0005581 |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 1.70e-15 | 8 | 44 | 6 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 1.70e-15 | 8 | 44 | 6 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 1.70e-15 | 8 | 44 | 6 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 COL1A2 | 5.05e-15 | 530 | 44 | 16 | GO:0062023 |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 1.08e-13 | 332 | 44 | 13 | GO:0005788 |
| GeneOntologyCellularComponent | extracellular matrix | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 COL1A2 | 1.36e-13 | 656 | 44 | 16 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 COL1A2 | 1.42e-13 | 658 | 44 | 16 | GO:0030312 |
| GeneOntologyCellularComponent | collagen type IV trimer | 1.96e-13 | 6 | 44 | 5 | GO:0005587 | |
| GeneOntologyCellularComponent | basement membrane | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL7A1 COL8A1 | 3.48e-12 | 122 | 44 | 9 | GO:0005604 |
| GeneOntologyCellularComponent | supramolecular polymer | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 MYOZ3 COL5A1 KRT5 KRT6A KRT6B COL8A1 ELN COL11A2 FBN2 KRT6C COL1A2 | 9.73e-10 | 1187 | 44 | 16 | GO:0099081 |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.89e-06 | 12 | 44 | 3 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.89e-06 | 12 | 44 | 3 | GO:0098643 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 4.31e-05 | 5 | 44 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | keratin filament | 5.13e-05 | 97 | 44 | 4 | GO:0045095 | |
| GeneOntologyCellularComponent | supramolecular fiber | 1.34e-04 | 1179 | 44 | 10 | GO:0099512 | |
| GeneOntologyCellularComponent | intermediate filament | 1.31e-03 | 227 | 44 | 4 | GO:0005882 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 2.24e-03 | 263 | 44 | 4 | GO:0045111 | |
| GeneOntologyCellularComponent | chromatin | 1.11e-02 | 1480 | 44 | 8 | GO:0000785 | |
| GeneOntologyCellularComponent | endoplasmic reticulum-Golgi intermediate compartment membrane | 1.26e-02 | 81 | 44 | 2 | GO:0033116 | |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.74e-02 | 96 | 44 | 2 | GO:0070603 | |
| HumanPheno | Lenticonus | 6.52e-08 | 10 | 23 | 4 | HP:0001142 | |
| HumanPheno | Glomerular basement membrane lamellation | 8.04e-08 | 3 | 23 | 3 | HP:0030034 | |
| HumanPheno | Anterior lenticonus | 8.04e-08 | 3 | 23 | 3 | HP:0011501 | |
| HumanPheno | Palmoplantar blistering | 1.02e-07 | 11 | 23 | 4 | HP:0007446 | |
| HumanPheno | Atrophic scars | 4.68e-07 | 37 | 23 | 5 | HP:0001075 | |
| HumanPheno | Abnormality of lens shape | 9.27e-07 | 18 | 23 | 4 | HP:0011526 | |
| HumanPheno | Glomerular deposits | 1.46e-06 | 20 | 23 | 4 | HP:0030949 | |
| HumanPheno | Onychogryposis of toenails | 2.78e-06 | 7 | 23 | 3 | HP:0008401 | |
| HumanPheno | Onychogryposis | 2.78e-06 | 7 | 23 | 3 | HP:0001819 | |
| HumanPheno | Blistering by anatomical location | 4.42e-06 | 26 | 23 | 4 | HP:0033800 | |
| HumanPheno | Onychogryposis of fingernail | 6.64e-06 | 9 | 23 | 3 | HP:0040036 | |
| HumanPheno | Onychogryposis | 6.96e-06 | 29 | 23 | 4 | HP:0001805 | |
| HumanPheno | Myopia | COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 ELN COL11A2 BCL11B FBN2 COL1A2 | 9.84e-06 | 447 | 23 | 10 | HP:0000545 |
| HumanPheno | Atypical scarring of skin | 1.55e-05 | 74 | 23 | 5 | HP:0000987 | |
| HumanPheno | Thickened glomerular basement membrane | 1.72e-05 | 12 | 23 | 3 | HP:0004722 | |
| HumanPheno | Fragile skin | 1.89e-05 | 37 | 23 | 4 | HP:0001030 | |
| HumanPheno | Tracheobronchial leiomyomatosis | 1.95e-05 | 2 | 23 | 2 | HP:0006524 | |
| HumanPheno | Dyspepsia | 1.95e-05 | 2 | 23 | 2 | HP:0410281 | |
| HumanPheno | Diffuse leiomyomatosis | 1.95e-05 | 2 | 23 | 2 | HP:0006756 | |
| HumanPheno | Abnormal glomerular basement membrane morphology | 2.23e-05 | 13 | 23 | 3 | HP:0033282 | |
| HumanPheno | Glomerular subepithelial deposits | 2.83e-05 | 14 | 23 | 3 | HP:0033603 | |
| HumanPheno | Vulvar neoplasm | 5.84e-05 | 3 | 23 | 2 | HP:0030416 | |
| HumanPheno | Precordial pain | 5.84e-05 | 3 | 23 | 2 | HP:0032141 | |
| HumanPheno | Thin glomerular basement membrane | 5.84e-05 | 3 | 23 | 2 | HP:0012577 | |
| HumanPheno | Scarring | 7.37e-05 | 102 | 23 | 5 | HP:0100699 | |
| HumanPheno | Dermal atrophy | 9.27e-05 | 107 | 23 | 5 | HP:0004334 | |
| HumanPheno | Abnormality of refraction | COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 KRT5 ELN COL11A2 BCL11B FBN2 COL1A2 | 9.64e-05 | 709 | 23 | 11 | HP:0000539 |
| HumanPheno | Limb pain | 1.07e-04 | 57 | 23 | 4 | HP:0009763 | |
| HumanPheno | Pretibial blistering | 1.16e-04 | 4 | 23 | 2 | HP:0012221 | |
| HumanPheno | Eruptive vellus hair cyst | 1.16e-04 | 4 | 23 | 2 | HP:0025248 | |
| HumanPheno | Steatocystoma multiplex | 1.16e-04 | 4 | 23 | 2 | HP:0012035 | |
| HumanPheno | Palmoplantar keratoderma | 1.25e-04 | 114 | 23 | 5 | HP:0000982 | |
| HumanPheno | Chronic kidney disease | 1.66e-04 | 194 | 23 | 6 | HP:0012622 | |
| HumanPheno | Linear arrays of macular hyperkeratoses in flexural areas | 1.93e-04 | 5 | 23 | 2 | HP:0007490 | |
| HumanPheno | Hyperplastic callus formation | 1.93e-04 | 5 | 23 | 2 | HP:0030268 | |
| HumanPheno | Dermal translucency | 2.19e-04 | 27 | 23 | 3 | HP:0010648 | |
| HumanPheno | Palmoplantar hyperkeratosis | 2.25e-04 | 129 | 23 | 5 | HP:0000972 | |
| HumanPheno | Small joint hypermobilty | 2.25e-04 | 69 | 23 | 4 | HP:0430046 | |
| HumanPheno | Aortic root aneurysm | 2.38e-04 | 70 | 23 | 4 | HP:0002616 | |
| HumanPheno | Palmar hyperkeratosis | 2.42e-04 | 131 | 23 | 5 | HP:0010765 | |
| HumanPheno | White lesion of the oral mucosa | 2.45e-04 | 28 | 23 | 3 | HP:0025125 | |
| HumanPheno | Oral leukoplakia | 2.45e-04 | 28 | 23 | 3 | HP:0002745 | |
| HumanPheno | Plantar hyperkeratosis | 2.50e-04 | 132 | 23 | 5 | HP:0007556 | |
| HumanPheno | Stage 5 chronic kidney disease | 2.78e-04 | 135 | 23 | 5 | HP:0003774 | |
| HumanPheno | Nephritis | 3.41e-04 | 141 | 23 | 5 | HP:0000123 | |
| HumanPheno | Esophageal stenosis | 4.02e-04 | 33 | 23 | 3 | HP:0010450 | |
| HumanPheno | Uterine prolapse | 4.04e-04 | 7 | 23 | 2 | HP:0000139 | |
| HumanPheno | Abnormal fingernail morphology | 4.19e-04 | 230 | 23 | 6 | HP:0001231 | |
| HumanPheno | Hyperkeratosis | 4.49e-04 | 233 | 23 | 6 | HP:0000962 | |
| HumanPheno | Dilatation of the ascending aorta | 4.80e-04 | 84 | 23 | 4 | HP:0005111 | |
| HumanPheno | Bladder diverticulum | 5.21e-04 | 36 | 23 | 3 | HP:0000015 | |
| HumanPheno | Genital hernia | 5.37e-04 | 8 | 23 | 2 | HP:0100823 | |
| HumanPheno | Arterial rupture | 5.37e-04 | 8 | 23 | 2 | HP:0025019 | |
| HumanPheno | Anti-smooth muscle antibody positivity | 5.37e-04 | 8 | 23 | 2 | HP:0003262 | |
| HumanPheno | Abnormal knee physiology | 5.49e-04 | 87 | 23 | 4 | HP:0034670 | |
| HumanPheno | Abnormality of keratinization | 5.76e-04 | 244 | 23 | 6 | HP:0001035 | |
| HumanPheno | Abnormal shoulder morphology | 6.01e-04 | 246 | 23 | 6 | HP:0003043 | |
| HumanPheno | Natal tooth | 6.12e-04 | 38 | 23 | 3 | HP:0000695 | |
| HumanPheno | Acral blistering | 6.89e-04 | 9 | 23 | 2 | HP:0031045 | |
| HumanPheno | Mitten deformity | 6.89e-04 | 9 | 23 | 2 | HP:0004057 | |
| HumanPheno | Hyperextensibility of the knee | 7.13e-04 | 40 | 23 | 3 | HP:0010500 | |
| HumanPheno | Abnormal sternum morphology | 7.37e-04 | 474 | 23 | 8 | HP:0000766 | |
| HumanPheno | Lower limb pain | 7.67e-04 | 41 | 23 | 3 | HP:0012514 | |
| HumanPheno | Abnormality of the plantar skin of foot | 8.27e-04 | 171 | 23 | 5 | HP:0100872 | |
| HumanPheno | Abnormal dermatological laboratory findings | 8.59e-04 | 10 | 23 | 2 | HP:0003340 | |
| HumanPheno | Lamina lucida cleavage | 8.59e-04 | 10 | 23 | 2 | HP:0003341 | |
| HumanPheno | Cigarette-paper scars | 8.59e-04 | 10 | 23 | 2 | HP:0001073 | |
| HumanPheno | Vaginal neoplasm | 8.59e-04 | 10 | 23 | 2 | HP:0100650 | |
| HumanPheno | Abnormality of the knee | 9.33e-04 | 491 | 23 | 8 | HP:0002815 | |
| HumanPheno | Soft skin | 9.44e-04 | 44 | 23 | 3 | HP:0000977 | |
| HumanPheno | Epidermoid cyst | 1.01e-03 | 45 | 23 | 3 | HP:0200040 | |
| HumanPheno | Epidermal thickening | 1.03e-03 | 379 | 23 | 7 | HP:0011368 | |
| HumanPheno | Subepidermal blistering | 1.05e-03 | 11 | 23 | 2 | HP:0033804 | |
| HumanPheno | Advanced eruption of teeth | 1.08e-03 | 46 | 23 | 3 | HP:0006288 | |
| HumanPheno | Corneal erosion | 1.22e-03 | 48 | 23 | 3 | HP:0200020 | |
| HumanPheno | Angular cheilitis | 1.25e-03 | 12 | 23 | 2 | HP:0030318 | |
| HumanPheno | Erythematous papule | 1.25e-03 | 12 | 23 | 2 | HP:0030350 | |
| HumanPheno | Cutaneous cyst | 1.45e-03 | 51 | 23 | 3 | HP:0025245 | |
| HumanPheno | Soft tissue neoplasm | 1.48e-03 | 13 | 23 | 2 | HP:0031459 | |
| HumanPheno | Blistering by histological location | 1.48e-03 | 13 | 23 | 2 | HP:0033801 | |
| HumanPheno | Hyperkeratotic papule | 1.48e-03 | 13 | 23 | 2 | HP:0045059 | |
| HumanPheno | Finger joint hypermobility | 1.54e-03 | 52 | 23 | 3 | HP:0006094 | |
| HumanPheno | Poor wound healing | 1.54e-03 | 52 | 23 | 3 | HP:0001058 | |
| HumanPheno | Abnormal blistering of the skin | 1.57e-03 | 115 | 23 | 4 | HP:0008066 | |
| HumanPheno | Aplasia/Hypoplasia of the skin | 1.71e-03 | 201 | 23 | 5 | HP:0008065 | |
| HumanPheno | Palmoplantar hyperhidrosis | 1.72e-03 | 14 | 23 | 2 | HP:0007410 | |
| HumanPheno | Oral mucosal blisters | 1.72e-03 | 14 | 23 | 2 | HP:0200097 | |
| HumanPheno | Soft, doughy skin | 1.72e-03 | 14 | 23 | 2 | HP:0001027 | |
| HumanPheno | Abnormal thorax morphology | LAMA5 COL4A5 COL4A6 COL5A1 KRT5 COL6A2 ELN COL11A2 BCL11B FBN2 COL13A1 C19orf12 COL1A2 | 1.84e-03 | 1328 | 23 | 13 | HP:0000765 |
| HumanPheno | Thoracic aortic aneurysm | 1.89e-03 | 121 | 23 | 4 | HP:0012727 | |
| HumanPheno | Abnormality of the joints of the lower limbs | 1.90e-03 | 547 | 23 | 8 | HP:0100239 | |
| HumanPheno | Renal insufficiency | 1.91e-03 | 421 | 23 | 7 | HP:0000083 | |
| HumanPheno | Ear pain | 1.98e-03 | 15 | 23 | 2 | HP:0030766 | |
| HumanPheno | Abnormality of hand joint mobility | 2.01e-03 | 57 | 23 | 3 | HP:0006256 | |
| HumanPheno | Mitral valve prolapse | 2.01e-03 | 123 | 23 | 4 | HP:0001634 | |
| HumanPheno | Abdominal aortic aneurysm | 2.13e-03 | 125 | 23 | 4 | HP:0005112 | |
| HumanPheno | Pain | COL4A3 COL4A5 COL4A6 COL5A1 KRT5 KRT6A KRT6B COL7A1 ELN COL11A2 | 2.17e-03 | 846 | 23 | 10 | HP:0012531 |
| HumanPheno | Thickened skin | 2.19e-03 | 431 | 23 | 7 | HP:0001072 | |
| HumanPheno | Bowing of the long bones | 2.23e-03 | 316 | 23 | 6 | HP:0006487 | |
| HumanPheno | Achalasia | 2.25e-03 | 16 | 23 | 2 | HP:0002571 | |
| MousePheno | hematuria | 1.75e-07 | 19 | 38 | 4 | MP:0005161 | |
| MousePheno | abnormal renal glomerulus basement membrane morphology | 5.83e-06 | 44 | 38 | 4 | MP:0011348 | |
| MousePheno | renal interstitial fibrosis | 1.33e-05 | 54 | 38 | 4 | MP:0003215 | |
| MousePheno | abnormal kidney interstitium morphology | 3.15e-05 | 67 | 38 | 4 | MP:0011425 | |
| MousePheno | abnormal podocyte morphology | 3.74e-05 | 70 | 38 | 4 | MP:0005326 | |
| MousePheno | abnormal glomerular capsule visceral layer morphology | 3.74e-05 | 70 | 38 | 4 | MP:0011497 | |
| MousePheno | abnormal tongue epithelium morphology | 5.18e-05 | 27 | 38 | 3 | MP:0000764 | |
| MousePheno | increased renal glomerulus basement membrane thickness | 5.18e-05 | 27 | 38 | 3 | MP:0011409 | |
| MousePheno | renal fibrosis | 5.73e-05 | 78 | 38 | 4 | MP:0003985 | |
| MousePheno | renal tubule atrophy | 7.15e-05 | 30 | 38 | 3 | MP:0011346 | |
| MousePheno | renal glomerular synechia | 7.16e-05 | 5 | 38 | 2 | MP:0011483 | |
| MousePheno | abnormal glomerular mesangium morphology | 7.31e-05 | 83 | 38 | 4 | MP:0011339 | |
| MousePheno | abnormal renal glomerulus basement membrane thickness | 7.90e-05 | 31 | 38 | 3 | MP:0011349 | |
| MousePheno | pale kidney | 9.56e-05 | 33 | 38 | 3 | MP:0004969 | |
| MousePheno | decreased circulating amylase level | 1.35e-04 | 37 | 38 | 3 | MP:0008805 | |
| MousePheno | sensorineural hearing loss | 1.35e-04 | 37 | 38 | 3 | MP:0004740 | |
| MousePheno | abnormal mesangial cell morphology | 1.46e-04 | 38 | 38 | 3 | MP:0005327 | |
| MousePheno | increased large unstained cell number | 1.46e-04 | 38 | 38 | 3 | MP:0012362 | |
| MousePheno | sensorineural hearing impairment | 1.46e-04 | 38 | 38 | 3 | MP:0006329 | |
| MousePheno | podocyte foot process effacement | 1.46e-04 | 38 | 38 | 3 | MP:0008140 | |
| MousePheno | abnormal filiform papillae morphology | 1.50e-04 | 7 | 38 | 2 | MP:0000763 | |
| MousePheno | abnormal odontoblast morphology | 1.50e-04 | 7 | 38 | 2 | MP:0030453 | |
| MousePheno | abnormal basement membrane morphology | 1.71e-04 | 40 | 38 | 3 | MP:0004272 | |
| MousePheno | abnormal renal glomerular capsule morphology | 1.96e-04 | 107 | 38 | 4 | MP:0002828 | |
| MousePheno | kidney failure | 2.60e-04 | 46 | 38 | 3 | MP:0003606 | |
| MousePheno | expanded mesangial matrix | 2.60e-04 | 46 | 38 | 3 | MP:0011353 | |
| MousePheno | abnormal glomerular capillary morphology | 2.77e-04 | 47 | 38 | 3 | MP:0011320 | |
| MousePheno | abnormal tongue morphology | 2.85e-04 | 118 | 38 | 4 | MP:0000762 | |
| MousePheno | abnormal kidney capillary morphology | 2.95e-04 | 48 | 38 | 3 | MP:0011310 | |
| MousePheno | abnormal mesangial matrix morphology | 3.53e-04 | 51 | 38 | 3 | MP:0011338 | |
| MousePheno | kidney atrophy | 3.95e-04 | 53 | 38 | 3 | MP:0004970 | |
| MousePheno | abnormal large unstained cell number | 3.95e-04 | 53 | 38 | 3 | MP:0012360 | |
| MousePheno | abnormal podocyte foot process morphology | 4.41e-04 | 55 | 38 | 3 | MP:0008059 | |
| MousePheno | abnormal subclavian artery morphology | 4.65e-04 | 56 | 38 | 3 | MP:0003395 | |
| MousePheno | abnormal dental pulp morphology | 4.67e-04 | 12 | 38 | 2 | MP:0013250 | |
| MousePheno | abnormal epidermal-dermal junction morphology | 4.67e-04 | 12 | 38 | 2 | MP:0011159 | |
| MousePheno | abnormal facial morphology | 5.91e-04 | 910 | 38 | 9 | MP:0003743 | |
| MousePheno | abnormal head morphology | COL4A2 LAMA5 KRT5 KRT6A KRT6B COL7A1 MEF2B COL11A2 BCL11B SSUH2 | 6.20e-04 | 1120 | 38 | 10 | MP:0000432 |
| MousePheno | absent T cells | 6.41e-04 | 14 | 38 | 2 | MP:0008070 | |
| MousePheno | albuminuria | 6.58e-04 | 63 | 38 | 3 | MP:0002871 | |
| MousePheno | increased urine protein level | 6.90e-04 | 149 | 38 | 4 | MP:0002962 | |
| MousePheno | abnormal esophagus morphology | 7.54e-04 | 66 | 38 | 3 | MP:0000467 | |
| MousePheno | craniofacial phenotype | COL4A2 LAMA5 KRT5 KRT6A KRT6B COL7A1 MEF2B COL11A2 BCL11B FBN2 SSUH2 | 7.74e-04 | 1372 | 38 | 11 | MP:0005382 |
| MousePheno | abnormal craniofacial morphology | COL4A2 LAMA5 KRT5 KRT6A KRT6B COL7A1 MEF2B COL11A2 BCL11B FBN2 SSUH2 | 7.74e-04 | 1372 | 38 | 11 | MP:0000428 |
| MousePheno | abnormal epidermal layer morphology | 7.85e-04 | 271 | 38 | 5 | MP:0001216 | |
| MousePheno | abnormal circulating amylase level | 8.20e-04 | 156 | 38 | 4 | MP:0008804 | |
| MousePheno | glomerulosclerosis | 8.22e-04 | 68 | 38 | 3 | MP:0005264 | |
| MousePheno | abnormal dental pulp cavity morphology | 8.43e-04 | 16 | 38 | 2 | MP:0002819 | |
| MousePheno | abnormal kidney vasculature morphology | 1.01e-03 | 73 | 38 | 3 | MP:0000530 | |
| MousePheno | abnormal urine protein level | 1.13e-03 | 170 | 38 | 4 | MP:0006315 | |
| MousePheno | glomerular crescent | 1.20e-03 | 19 | 38 | 2 | MP:0011506 | |
| MousePheno | abnormal skin morphology | LAMA5 COL5A1 KRT5 KRT6A KRT6B COL7A1 BCL11B FBN2 CHD5 DUSP8 COL1A2 | 1.26e-03 | 1455 | 38 | 11 | MP:0002060 |
| MousePheno | abnormal dentin development | 1.46e-03 | 21 | 38 | 2 | MP:0030542 | |
| MousePheno | tubulointerstitial nephritis | 1.91e-03 | 24 | 38 | 2 | MP:0011405 | |
| MousePheno | abnormal mouth morphology | 1.94e-03 | 670 | 38 | 7 | MP:0000452 | |
| MousePheno | abnormal capillary morphology | 2.03e-03 | 93 | 38 | 3 | MP:0003658 | |
| MousePheno | abnormal dentin morphology | 2.42e-03 | 27 | 38 | 2 | MP:0002818 | |
| MousePheno | decreased circulating protein level | 2.44e-03 | 698 | 38 | 7 | MP:0014502 | |
| MousePheno | abnormal extracellular matrix morphology | 2.50e-03 | 100 | 38 | 3 | MP:0013258 | |
| MousePheno | dilated renal tubule | 2.57e-03 | 101 | 38 | 3 | MP:0002705 | |
| MousePheno | abnormal kidney size | 2.78e-03 | 714 | 38 | 7 | MP:0002706 | |
| MousePheno | increased mesangial cell number | 2.79e-03 | 29 | 38 | 2 | MP:0011427 | |
| Domain | Collagen | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 8.93e-21 | 85 | 45 | 13 | PF01391 |
| Domain | Collagen | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 8.93e-21 | 85 | 45 | 13 | IPR008160 |
| Domain | C4 | 3.87e-13 | 6 | 45 | 5 | SM00111 | |
| Domain | - | 3.87e-13 | 6 | 45 | 5 | 2.170.240.10 | |
| Domain | Collagen_VI_NC | 3.87e-13 | 6 | 45 | 5 | IPR001442 | |
| Domain | NC1_IV | 3.87e-13 | 6 | 45 | 5 | PS51403 | |
| Domain | C4 | 3.87e-13 | 6 | 45 | 5 | PF01413 | |
| Domain | NC1_FIB | 9.58e-09 | 11 | 45 | 4 | PS51461 | |
| Domain | Fib_collagen_C | 9.58e-09 | 11 | 45 | 4 | IPR000885 | |
| Domain | Fib_collagen_C | 9.58e-09 | 11 | 45 | 4 | PD002078 | |
| Domain | COLFI | 9.58e-09 | 11 | 45 | 4 | SM00038 | |
| Domain | COLFI | 9.58e-09 | 11 | 45 | 4 | PF01410 | |
| Domain | Keratin_2_head | 3.02e-07 | 24 | 45 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 3.02e-07 | 24 | 45 | 4 | PF16208 | |
| Domain | Keratin_II | 4.23e-07 | 26 | 45 | 4 | IPR003054 | |
| Domain | Laminin_G_2 | 2.52e-06 | 40 | 45 | 4 | PF02210 | |
| Domain | CTDL_fold | 5.72e-06 | 107 | 45 | 5 | IPR016187 | |
| Domain | Laminin_G | 1.13e-05 | 58 | 45 | 4 | IPR001791 | |
| Domain | Intermediate_filament_CS | 1.58e-05 | 63 | 45 | 4 | IPR018039 | |
| Domain | TSPN | 2.24e-05 | 23 | 45 | 3 | SM00210 | |
| Domain | Filament | 2.54e-05 | 71 | 45 | 4 | SM01391 | |
| Domain | IF | 2.68e-05 | 72 | 45 | 4 | PS00226 | |
| Domain | Filament | 2.83e-05 | 73 | 45 | 4 | PF00038 | |
| Domain | IF | 3.32e-05 | 76 | 45 | 4 | IPR001664 | |
| Domain | - | 7.98e-05 | 95 | 45 | 4 | 2.60.120.200 | |
| Domain | LAM_G_DOMAIN | 1.04e-04 | 38 | 45 | 3 | PS50025 | |
| Domain | LamG | 1.62e-04 | 44 | 45 | 3 | SM00282 | |
| Domain | ConA-like_dom | 1.88e-03 | 219 | 45 | 4 | IPR013320 | |
| Domain | VWA | 8.05e-03 | 56 | 45 | 2 | PF00092 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 5.28e-25 | 44 | 35 | 13 | M27812 |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 4.93e-23 | 41 | 35 | 12 | MM15538 |
| Pathway | PID_SYNDECAN_1_PATHWAY | COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 2.41e-22 | 46 | 35 | 12 | M198 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 2.50e-22 | 67 | 35 | 13 | M26999 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 COL1A2 | 1.15e-21 | 140 | 35 | 15 | M587 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 1.64e-21 | 53 | 35 | 12 | MM14566 |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 COL1A2 | 4.52e-21 | 114 | 35 | 14 | MM14571 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL1A2 | 1.05e-20 | 61 | 35 | 12 | M27103 |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 1.05e-20 | 61 | 35 | 12 | MM14637 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 1.56e-20 | 90 | 35 | 13 | M631 |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 1.98e-20 | 64 | 35 | 12 | M26953 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 ITGA5 COL1A2 | 7.70e-20 | 300 | 35 | 17 | M610 |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL8A1 COL11A2 COL1A2 | 1.34e-19 | 50 | 35 | 11 | MM14796 |
| Pathway | REACTOME_COLLAGEN_FORMATION | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 1.84e-19 | 76 | 35 | 12 | MM14573 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL8A1 COL13A1 ITGA5 COL1A2 | 1.84e-19 | 76 | 35 | 12 | MM14867 |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL8A1 COL13A1 ITGA5 COL1A2 | 7.68e-19 | 85 | 35 | 12 | M16441 |
| Pathway | PID_INTEGRIN1_PATHWAY | COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL11A2 ITGA5 COL1A2 | 3.77e-18 | 66 | 35 | 11 | M18 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 ITGA5 COL1A2 | 1.35e-17 | 258 | 35 | 15 | MM14572 |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 1.45e-17 | 74 | 35 | 11 | M160 |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 1.95e-15 | 15 | 35 | 7 | M27161 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 6.16e-15 | 32 | 35 | 8 | MM14924 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL11A2 COL1A2 | 1.35e-14 | 59 | 35 | 9 | M27218 |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL6A2 COL1A2 | 1.49e-13 | 76 | 35 | 9 | M27219 |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | COL4A2 COL4A4 LAMA5 COL4A6 COL5A1 COL6A2 COL11A2 ITGA5 COL1A2 | 3.80e-13 | 84 | 35 | 9 | M7098 |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 6.00e-13 | 30 | 35 | 7 | M27216 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.71e-12 | 18 | 35 | 6 | M27164 | |
| Pathway | REACTOME_CROSSLINKING_OF_COLLAGEN_FIBRILS | 2.71e-12 | 18 | 35 | 6 | MM14882 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 5.64e-12 | 20 | 35 | 6 | MM15061 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.75e-11 | 10 | 35 | 5 | M22040 | |
| Pathway | BIOCARTA_NPP1_PATHWAY | 1.75e-11 | 10 | 35 | 5 | MM1560 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 3.20e-11 | 11 | 35 | 5 | M15422 | |
| Pathway | BIOCARTA_VITCB_PATHWAY | 5.48e-11 | 12 | 35 | 5 | MM1526 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 8.88e-11 | 13 | 35 | 5 | MM1347 | |
| Pathway | BIOCARTA_ACE2_PATHWAY | 8.88e-11 | 13 | 35 | 5 | M12950 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.38e-10 | 14 | 35 | 5 | MM1458 | |
| Pathway | BIOCARTA_PLATELETAPP_PATHWAY | 1.38e-10 | 14 | 35 | 5 | M6487 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.07e-10 | 15 | 35 | 5 | MM14922 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 3.89e-10 | 38 | 35 | 6 | MM14969 | |
| Pathway | WP_FOCAL_ADHESION | COL4A2 COL4A4 LAMA5 COL4A6 COL5A1 COL6A2 COL11A2 ITGA5 COL1A2 | 5.50e-10 | 187 | 35 | 9 | MM15913 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 7.34e-10 | 42 | 35 | 6 | M7169 | |
| Pathway | KEGG_FOCAL_ADHESION | COL4A2 COL4A4 LAMA5 COL4A6 COL5A1 COL6A2 COL11A2 ITGA5 COL1A2 | 9.55e-10 | 199 | 35 | 9 | M7253 |
| Pathway | BIOCARTA_AMI_PATHWAY | 1.06e-09 | 20 | 35 | 5 | M15394 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.28e-09 | 23 | 35 | 5 | M15997 | |
| Pathway | BIOCARTA_INTRINSIC_PATHWAY | 2.28e-09 | 23 | 35 | 5 | MM1427 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.94e-09 | 57 | 35 | 6 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 5.50e-09 | 58 | 35 | 6 | M2049 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 9.16e-09 | 63 | 35 | 6 | M11187 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 9.55e-09 | 30 | 35 | 5 | M27772 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 KRT5 COL6A2 KRT6A KRT6B MEF2B ITGA5 | 2.01e-08 | 502 | 35 | 11 | MM14537 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | COL4A2 COL4A4 LAMA5 COL4A6 COL5A1 COL6A2 COL11A2 ITGA5 COL1A2 | 3.65e-08 | 302 | 35 | 9 | M39719 |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 4.92e-08 | 41 | 35 | 5 | M27778 | |
| Pathway | PID_INTEGRIN3_PATHWAY | 6.30e-08 | 43 | 35 | 5 | M53 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | COL4A2 COL4A4 LAMA5 COL4A6 COL5A1 COL6A2 COL11A2 ITGA5 COL1A2 | 7.04e-08 | 326 | 35 | 9 | MM15917 |
| Pathway | WP_PI3KAKT_SIGNALING | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL6A2 ITGA5 COL1A2 | 9.84e-08 | 339 | 35 | 9 | M39736 |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.18e-07 | 96 | 35 | 6 | M39834 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL5A1 COL24A1 COL6A2 COL11A2 COL1A2 | 4.22e-07 | 532 | 35 | 10 | M27870 |
| Pathway | WP_FOCAL_ADHESION | 4.84e-07 | 199 | 35 | 7 | M39402 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 1.38e-06 | 79 | 35 | 5 | M27643 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.49e-06 | 161 | 35 | 6 | M39770 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.97e-06 | 261 | 35 | 7 | MM15676 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 3.67e-06 | 43 | 35 | 4 | M39565 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 6.51e-06 | 418 | 35 | 8 | MM15587 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.32e-05 | 19 | 35 | 3 | MM15512 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.91e-05 | 72 | 35 | 4 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 3.07e-05 | 73 | 35 | 4 | MM15906 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 5.34e-05 | 84 | 35 | 4 | M3228 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.44e-05 | 30 | 35 | 3 | MM15517 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL4A2 COL4A3 COL4A4 COL4A5 COL5A1 KRT5 COL6A2 KRT6A KRT6B MEF2B ITGA5 KRT6C | 1.04e-04 | 1432 | 35 | 12 | M509 |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.21e-04 | 39 | 35 | 3 | MM14601 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.73e-04 | 44 | 35 | 3 | M26969 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 1.85e-04 | 45 | 35 | 3 | M39864 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 2.11e-04 | 47 | 35 | 3 | MM14925 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 2.81e-04 | 129 | 35 | 4 | M27649 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 4.50e-04 | 575 | 35 | 7 | M29853 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 6.02e-04 | 67 | 35 | 3 | MM15345 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 6.64e-04 | 439 | 35 | 6 | M42563 | |
| Pathway | REACTOME_SCAVENGING_BY_CLASS_A_RECEPTORS | 9.97e-04 | 19 | 35 | 2 | M27221 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 1.29e-03 | 87 | 35 | 3 | MM15351 | |
| Pathway | WP_CANCER_PATHWAYS | 1.40e-03 | 507 | 35 | 6 | M48302 | |
| Pathway | PID_LYMPH_ANGIOGENESIS_PATHWAY | 1.73e-03 | 25 | 35 | 2 | M274 | |
| Pathway | REACTOME_KERATINIZATION | 1.97e-03 | 217 | 35 | 4 | M27640 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 2.02e-03 | 27 | 35 | 2 | M27217 | |
| Pathway | WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING | 2.17e-03 | 28 | 35 | 2 | MM15957 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.49e-03 | 30 | 35 | 2 | MM15812 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 2.49e-03 | 30 | 35 | 2 | M39641 | |
| Pathway | WP_BURN_WOUND_HEALING | 2.72e-03 | 113 | 35 | 3 | M42571 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 2.83e-03 | 32 | 35 | 2 | MM14854 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 3.78e-03 | 37 | 35 | 2 | M27134 | |
| Pathway | PID_DELTA_NP63_PATHWAY | 6.04e-03 | 47 | 35 | 2 | M236 | |
| Pathway | WP_PANCREATIC_CANCER_SUBTYPES | 6.29e-03 | 48 | 35 | 2 | M48093 | |
| Pathway | REACTOME_KERATINIZATION | 6.36e-03 | 153 | 35 | 3 | MM15343 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 8.27e-03 | 325 | 35 | 4 | M12868 | |
| Pathway | PID_ATF2_PATHWAY | 9.38e-03 | 59 | 35 | 2 | M166 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 9.38e-03 | 59 | 35 | 2 | M11215 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | COL4A2 COL4A3 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 COL1A2 | 9.58e-26 | 135 | 45 | 15 | 28675934 |
| Pubmed | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL1A2 | 5.50e-24 | 175 | 45 | 15 | 28071719 | |
| Pubmed | COL4A2 COL4A3 COL4A4 LAMA5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL13A1 COL1A2 | 8.88e-21 | 153 | 45 | 13 | 25037231 | |
| Pubmed | COL4A2 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 ELN COL13A1 COL1A2 | 2.52e-18 | 167 | 45 | 12 | 22159717 | |
| Pubmed | Proteomic characterization of human multiple myeloma bone marrow extracellular matrix. | COL4A2 COL4A3 COL4A5 COL4A6 COL5A1 COL6A2 COL7A1 COL11A2 COL1A2 | 8.35e-17 | 62 | 45 | 9 | 28344315 |
| Pubmed | 2.78e-16 | 9 | 45 | 6 | 9878537 | ||
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 8.34e-16 | 79 | 45 | 9 | 18757743 | |
| Pubmed | Matrilin-2 interacts with itself and with other extracellular matrix proteins. | 3.05e-15 | 12 | 45 | 6 | 12180907 | |
| Pubmed | Stimulation of extracellular matrix components in the normal brain by invading glioma cells. | 1.73e-14 | 6 | 45 | 5 | 9506531 | |
| Pubmed | 1.73e-14 | 6 | 45 | 5 | 2426947 | ||
| Pubmed | Angiogenesis and collagen type IV expression in different endothelial cell culture systems. | 1.73e-14 | 6 | 45 | 5 | 23551189 | |
| Pubmed | Monoclonal antibody to human basement membrane collagen type IV. | 1.73e-14 | 6 | 45 | 5 | 6811420 | |
| Pubmed | Immunolocalization of collagen types, laminin and fibronectin in the normal human pancreas. | 1.73e-14 | 6 | 45 | 5 | 6389236 | |
| Pubmed | 1.73e-14 | 6 | 45 | 5 | 12225806 | ||
| Pubmed | Insertional mutation of the collagen genes Col4a3 and Col4a4 in a mouse model of Alport syndrome. | 1.73e-14 | 6 | 45 | 5 | 10534397 | |
| Pubmed | A tumor derived motility factor that stimulates cell migration on extracellular matrix. | 1.73e-14 | 6 | 45 | 5 | 9673377 | |
| Pubmed | 1.73e-14 | 6 | 45 | 5 | 11732842 | ||
| Pubmed | Developmental distribution of collagen IV isoforms and relevance to ocular diseases. | 1.73e-14 | 6 | 45 | 5 | 19275937 | |
| Pubmed | 1.73e-14 | 6 | 45 | 5 | 6988303 | ||
| Pubmed | 2.63e-14 | 16 | 45 | 6 | 15878328 | ||
| Pubmed | 6.04e-14 | 7 | 45 | 5 | 11711546 | ||
| Pubmed | Regulation of protease nexin-1 target protease specificity by collagen type IV. | 6.04e-14 | 7 | 45 | 5 | 8006028 | |
| Pubmed | 6.04e-14 | 7 | 45 | 5 | 10416788 | ||
| Pubmed | 6.04e-14 | 7 | 45 | 5 | 1724753 | ||
| Pubmed | 8.88e-14 | 19 | 45 | 6 | 15689378 | ||
| Pubmed | 1.61e-13 | 8 | 45 | 5 | 3997552 | ||
| Pubmed | 1.61e-13 | 8 | 45 | 5 | 29422532 | ||
| Pubmed | 1.61e-13 | 8 | 45 | 5 | 1377218 | ||
| Pubmed | 1.61e-13 | 8 | 45 | 5 | 10382266 | ||
| Pubmed | 3.56e-13 | 50 | 45 | 7 | 23658023 | ||
| Pubmed | 3.62e-13 | 9 | 45 | 5 | 12101409 | ||
| Pubmed | 7.23e-13 | 10 | 45 | 5 | 9415455 | ||
| Pubmed | 7.23e-13 | 10 | 45 | 5 | 9136074 | ||
| Pubmed | 7.49e-13 | 26 | 45 | 6 | 24742657 | ||
| Pubmed | 1.32e-12 | 11 | 45 | 5 | 14998921 | ||
| Pubmed | Binding of mouse and human fibulin-2 to extracellular matrix ligands. | 1.32e-12 | 11 | 45 | 5 | 7500359 | |
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 2.27e-12 | 12 | 45 | 5 | 15837576 | |
| Pubmed | 2.27e-12 | 12 | 45 | 5 | 16024816 | ||
| Pubmed | 5.72e-12 | 14 | 45 | 5 | 12878203 | ||
| Pubmed | 8.57e-12 | 15 | 45 | 5 | 10625553 | ||
| Pubmed | 8.57e-12 | 15 | 45 | 5 | 9264260 | ||
| Pubmed | 1.23e-11 | 40 | 45 | 6 | 27068110 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 1.85e-11 | 86 | 45 | 7 | 28327460 | |
| Pubmed | 3.66e-11 | 6 | 45 | 4 | 7495302 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 4.38e-11 | 97 | 45 | 7 | 27559042 | |
| Pubmed | 5.78e-11 | 21 | 45 | 5 | 27856617 | ||
| Pubmed | 8.53e-11 | 7 | 45 | 4 | 10639489 | ||
| Pubmed | Hypoplastic basement membrane of the lens anlage in the inheritable lens aplastic mouse (lap mouse). | 8.53e-11 | 7 | 45 | 4 | 10716744 | |
| Pubmed | 8.53e-11 | 7 | 45 | 4 | 7521231 | ||
| Pubmed | 1.05e-10 | 186 | 45 | 8 | 20673868 | ||
| Pubmed | 1.05e-10 | 186 | 45 | 8 | 20452482 | ||
| Pubmed | Molecular properties of wild-type and mutant betaIG-H3 proteins. | 1.70e-10 | 8 | 45 | 4 | 11867580 | |
| Pubmed | 1.70e-10 | 8 | 45 | 4 | 11683410 | ||
| Pubmed | Discoidin domain receptor 1 functions in axon extension of cerebellar granule neurons. | 1.70e-10 | 8 | 45 | 4 | 10970885 | |
| Pubmed | 2.75e-10 | 210 | 45 | 8 | 16537572 | ||
| Pubmed | 3.07e-10 | 9 | 45 | 4 | 8562707 | ||
| Pubmed | 3.07e-10 | 9 | 45 | 4 | 10880400 | ||
| Pubmed | 4.78e-10 | 31 | 45 | 5 | 22925884 | ||
| Pubmed | 5.66e-10 | 32 | 45 | 5 | 23154389 | ||
| Pubmed | Large-scale identification of genes implicated in kidney glomerulus development and function. | 7.80e-10 | 34 | 45 | 5 | 16498405 | |
| Pubmed | Sensory ataxia and muscle spindle agenesis in mice lacking the transcription factor Egr3. | 8.01e-10 | 11 | 45 | 4 | 9731539 | |
| Pubmed | 1.20e-09 | 12 | 45 | 4 | 8918877 | ||
| Pubmed | 1.61e-09 | 39 | 45 | 5 | 33580754 | ||
| Pubmed | Basal lamina molecules are concentrated in myogenic regions of the mouse limb bud. | 1.73e-09 | 13 | 45 | 4 | 9833687 | |
| Pubmed | FOXD1 is required for 3D patterning of the kidney interstitial matrix. | 1.73e-09 | 13 | 45 | 4 | 36335435 | |
| Pubmed | Collagen IV diseases: A focus on the glomerular basement membrane in Alport syndrome. | 2.02e-09 | 3 | 45 | 3 | 27576055 | |
| Pubmed | Novel COL4A5, COL4A4, and COL4A3 mutations in Alport syndrome. | 2.02e-09 | 3 | 45 | 3 | 15954103 | |
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 29357356 | ||
| Pubmed | Alport syndrome: impact of digenic inheritance in patients management. | 2.02e-09 | 3 | 45 | 3 | 27859054 | |
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 17396119 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 24522496 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 3089234 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 29587848 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 7962065 | ||
| Pubmed | Novel mutations in COL4A3, COL4A4, and COL4A5 in Chinese patients with Alport Syndrome. | 2.02e-09 | 3 | 45 | 3 | 28542346 | |
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 28704582 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 18930919 | ||
| Pubmed | Integration of Genetic Testing and Pathology for the Diagnosis of Adults with FSGS. | 2.02e-09 | 3 | 45 | 3 | 30647093 | |
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 7543104 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 38978054 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 20301386 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 36130833 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 14507670 | ||
| Pubmed | Genetic diagnosis of Alport syndrome in 16 Chinese families. | 2.02e-09 | 3 | 45 | 3 | 38433557 | |
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 25575550 | ||
| Pubmed | COL4A6 is dispensable for autosomal recessive Alport syndrome. | 2.02e-09 | 3 | 45 | 3 | 27377778 | |
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 24033287 | ||
| Pubmed | 2.02e-09 | 3 | 45 | 3 | 14633121 | ||
| Pubmed | 2.42e-09 | 14 | 45 | 4 | 19858219 | ||
| Pubmed | Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. | 3.30e-09 | 15 | 45 | 4 | 10706142 | |
| Pubmed | Proteomics characterization of extracellular space components in the human aorta. | 3.83e-09 | 101 | 45 | 6 | 20551380 | |
| Pubmed | 7.38e-09 | 18 | 45 | 4 | 9160753 | ||
| Pubmed | Nature and the multiple functions of the 67-kD elastin-/laminin binding protein. | 8.09e-09 | 4 | 45 | 3 | 7827955 | |
| Pubmed | 8.09e-09 | 4 | 45 | 3 | 12874293 | ||
| Pubmed | 1.17e-08 | 20 | 45 | 4 | 38113115 | ||
| Pubmed | 1.44e-08 | 21 | 45 | 4 | 23325811 | ||
| Pubmed | Airway hillocks are injury-resistant reservoirs of unique plastic stem cells. | 2.02e-08 | 5 | 45 | 3 | 38693267 | |
| Pubmed | 2.02e-08 | 5 | 45 | 3 | 9409248 | ||
| Pubmed | Role for keratins 6 and 17 during wound closure in embryonic mouse skin. | 2.02e-08 | 5 | 45 | 3 | 12557214 | |
| Pubmed | 2.02e-08 | 5 | 45 | 3 | 20301457 | ||
| Interaction | MMP9 interactions | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 ITGA5 COL1A2 | 1.84e-14 | 67 | 44 | 9 | int:MMP9 |
| Interaction | FBLN2 interactions | 1.38e-12 | 66 | 44 | 8 | int:FBLN2 | |
| Interaction | DCN interactions | 4.35e-12 | 43 | 44 | 7 | int:DCN | |
| Interaction | LAIR2 interactions | 1.15e-11 | 49 | 44 | 7 | int:LAIR2 | |
| Interaction | HABP2 interactions | 3.29e-10 | 18 | 44 | 5 | int:HABP2 | |
| Interaction | COL8A2 interactions | 3.76e-10 | 42 | 44 | 6 | int:COL8A2 | |
| Interaction | CD93 interactions | 5.81e-10 | 45 | 44 | 6 | int:CD93 | |
| Interaction | OSM interactions | 5.94e-10 | 20 | 44 | 5 | int:OSM | |
| Interaction | MMP2 interactions | 3.36e-08 | 87 | 44 | 6 | int:MMP2 | |
| Interaction | PHTF1 interactions | 9.33e-08 | 20 | 44 | 4 | int:PHTF1 | |
| Interaction | EFNA3 interactions | 1.23e-07 | 108 | 44 | 6 | int:EFNA3 | |
| Interaction | SERPINE2 interactions | 1.38e-07 | 56 | 44 | 5 | int:SERPINE2 | |
| Interaction | MATN2 interactions | 1.61e-07 | 113 | 44 | 6 | int:MATN2 | |
| Interaction | TGFBI interactions | 2.42e-07 | 25 | 44 | 4 | int:TGFBI | |
| Interaction | COL5A1 interactions | 2.94e-07 | 65 | 44 | 5 | int:COL5A1 | |
| Interaction | COLGALT2 interactions | 3.43e-07 | 67 | 44 | 5 | int:COLGALT2 | |
| Interaction | ANTXR2 interactions | 4.51e-07 | 29 | 44 | 4 | int:ANTXR2 | |
| Interaction | KRT28 interactions | 5.20e-07 | 30 | 44 | 4 | int:KRT28 | |
| Interaction | KRT36 interactions | 5.65e-07 | 74 | 44 | 5 | int:KRT36 | |
| Interaction | KRT25 interactions | 9.85e-07 | 35 | 44 | 4 | int:KRT25 | |
| Interaction | FN1 interactions | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 KRT5 COL6A2 COL7A1 COL13A1 ITGA5 COL1A2 | 1.47e-06 | 848 | 44 | 11 | int:FN1 |
| Interaction | MFAP2 interactions | 2.11e-06 | 12 | 44 | 3 | int:MFAP2 | |
| Interaction | TIMP2 interactions | 2.13e-06 | 277 | 44 | 7 | int:TIMP2 | |
| Interaction | EFNA1 interactions | 2.93e-06 | 103 | 44 | 5 | int:EFNA1 | |
| Interaction | PLOD1 interactions | 3.02e-06 | 292 | 44 | 7 | int:PLOD1 | |
| Interaction | C1QTNF1 interactions | 3.29e-06 | 47 | 44 | 4 | int:C1QTNF1 | |
| Interaction | KRT84 interactions | 3.90e-06 | 49 | 44 | 4 | int:KRT84 | |
| Interaction | FBN1 interactions | 4.58e-06 | 51 | 44 | 4 | int:FBN1 | |
| Interaction | KRT20 interactions | 1.07e-05 | 63 | 44 | 4 | int:KRT20 | |
| Interaction | KRT12 interactions | 1.90e-05 | 24 | 44 | 3 | int:KRT12 | |
| Interaction | RNF208 interactions | 2.15e-05 | 75 | 44 | 4 | int:RNF208 | |
| Interaction | KRT7 interactions | 2.77e-05 | 80 | 44 | 4 | int:KRT7 | |
| Interaction | COL5A2 interactions | 3.41e-05 | 29 | 44 | 3 | int:COL5A2 | |
| Interaction | BGN interactions | 3.78e-05 | 30 | 44 | 3 | int:BGN | |
| Interaction | KRT75 interactions | 4.52e-05 | 181 | 44 | 5 | int:KRT75 | |
| Interaction | DAZAP2 interactions | 5.15e-05 | 186 | 44 | 5 | int:DAZAP2 | |
| Interaction | KRT26 interactions | 6.05e-05 | 35 | 44 | 3 | int:KRT26 | |
| Interaction | KRTAP19-5 interactions | 6.40e-05 | 99 | 44 | 4 | int:KRTAP19-5 | |
| Interaction | KRT37 interactions | 6.65e-05 | 100 | 44 | 4 | int:KRT37 | |
| Interaction | KRT27 interactions | 7.61e-05 | 202 | 44 | 5 | int:KRT27 | |
| Interaction | KRT35 interactions | 9.98e-05 | 111 | 44 | 4 | int:KRT35 | |
| Interaction | C1QC interactions | 1.05e-04 | 42 | 44 | 3 | int:C1QC | |
| Interaction | KRT13 interactions | 1.18e-04 | 116 | 44 | 4 | int:KRT13 | |
| Interaction | NID1 interactions | 1.57e-04 | 48 | 44 | 3 | int:NID1 | |
| Interaction | COL4A1 interactions | 1.57e-04 | 48 | 44 | 3 | int:COL4A1 | |
| Interaction | COL5A3 interactions | 2.07e-04 | 10 | 44 | 2 | int:COL5A3 | |
| Interaction | SAA1 interactions | 2.23e-04 | 54 | 44 | 3 | int:SAA1 | |
| Interaction | KRT24 interactions | 2.23e-04 | 54 | 44 | 3 | int:KRT24 | |
| Interaction | C1QTNF2 interactions | 3.36e-04 | 62 | 44 | 3 | int:C1QTNF2 | |
| Interaction | COL9A1 interactions | 3.58e-04 | 13 | 44 | 2 | int:COL9A1 | |
| Interaction | SPARC interactions | 3.86e-04 | 65 | 44 | 3 | int:SPARC | |
| Interaction | DES interactions | 3.87e-04 | 158 | 44 | 4 | int:DES | |
| Interaction | KRT6A interactions | 4.06e-04 | 160 | 44 | 4 | int:KRT6A | |
| Interaction | KRT38 interactions | 5.33e-04 | 172 | 44 | 4 | int:KRT38 | |
| Interaction | COL4A2 interactions | 5.88e-04 | 75 | 44 | 3 | int:COL4A2 | |
| Interaction | KRT15 interactions | 6.06e-04 | 178 | 44 | 4 | int:KRT15 | |
| Interaction | KRT6C interactions | 6.11e-04 | 76 | 44 | 3 | int:KRT6C | |
| Interaction | COL1A2 interactions | 6.59e-04 | 78 | 44 | 3 | int:COL1A2 | |
| Interaction | PLOD3 interactions | 6.73e-04 | 183 | 44 | 4 | int:PLOD3 | |
| Interaction | THRB interactions | 7.15e-04 | 186 | 44 | 4 | int:THRB | |
| Interaction | KRT14 interactions | 8.05e-04 | 192 | 44 | 4 | int:KRT14 | |
| Interaction | KRT5 interactions | 8.20e-04 | 193 | 44 | 4 | int:KRT5 | |
| Interaction | CBL interactions | 8.46e-04 | 516 | 44 | 6 | int:CBL | |
| Interaction | DEFB125 interactions | 8.63e-04 | 20 | 44 | 2 | int:DEFB125 | |
| Interaction | CKMT2 interactions | 8.76e-04 | 86 | 44 | 3 | int:CKMT2 | |
| Interaction | NID2 interactions | 8.76e-04 | 86 | 44 | 3 | int:NID2 | |
| Interaction | KRT16 interactions | 8.86e-04 | 197 | 44 | 4 | int:KRT16 | |
| Interaction | PRPH interactions | 1.01e-03 | 204 | 44 | 4 | int:PRPH | |
| Interaction | KRT33B interactions | 1.10e-03 | 93 | 44 | 3 | int:KRT33B | |
| Interaction | C1QB interactions | 1.13e-03 | 94 | 44 | 3 | int:C1QB | |
| Interaction | HSPG2 interactions | 1.28e-03 | 98 | 44 | 3 | int:HSPG2 | |
| Interaction | COL7A1 interactions | 1.35e-03 | 25 | 44 | 2 | int:COL7A1 | |
| Interaction | KRTAP6-1 interactions | 1.47e-03 | 103 | 44 | 3 | int:KRTAP6-1 | |
| Cytoband | 12q13.13 | 5.90e-07 | 67 | 45 | 4 | 12q13.13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 5.85e-05 | 423 | 45 | 5 | chr12q13 | |
| Cytoband | Xq22 | 2.14e-04 | 22 | 45 | 2 | Xq22 | |
| Cytoband | 6p21.3 | 1.91e-03 | 250 | 45 | 3 | 6p21.3 | |
| Cytoband | 19q13.12 | 2.30e-03 | 72 | 45 | 2 | 19q13.12 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q36 | 3.18e-03 | 85 | 45 | 2 | chr2q36 | |
| Cytoband | 17q25.3 | 4.46e-03 | 101 | 45 | 2 | 17q25.3 | |
| GeneFamily | Collagens | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 4.10e-26 | 46 | 35 | 13 | 490 |
| GeneFamily | Keratins, type II | 2.00e-07 | 27 | 35 | 4 | 609 | |
| Coexpression | NABA_COLLAGENS | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 5.85e-27 | 43 | 45 | 13 | MM17060 |
| Coexpression | NABA_COLLAGENS | COL4A2 COL4A3 COL4A4 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 8.29e-27 | 44 | 45 | 13 | M3005 |
| Coexpression | NABA_CORE_MATRISOME | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 COL1A2 | 5.09e-21 | 270 | 45 | 16 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 COL1A2 | 6.84e-21 | 275 | 45 | 16 | M5884 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 6.47e-15 | 23 | 45 | 7 | M48001 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 4.81e-13 | 40 | 45 | 7 | M5887 | |
| Coexpression | NABA_MATRISOME | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 COL1A2 | 4.61e-12 | 1008 | 45 | 16 | MM17056 |
| Coexpression | NABA_MATRISOME | COL4A2 COL4A3 COL4A4 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 COL1A2 | 6.02e-12 | 1026 | 45 | 16 | M5889 |
| Coexpression | GU_PDEF_TARGETS_UP | 3.30e-11 | 71 | 45 | 7 | M3955 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 9.31e-10 | 27 | 45 | 5 | M47994 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.69e-09 | 200 | 45 | 8 | M5930 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | COL4A2 LAMA5 COL4A5 COL4A6 COL5A1 COL6A2 COL13A1 ITGA5 ARHGEF17 COL1A2 | 1.12e-08 | 505 | 45 | 10 | M39167 |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 1.77e-08 | 17 | 45 | 4 | M47995 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 1.74e-07 | 29 | 45 | 4 | MM17055 | |
| Coexpression | KANG_IMMORTALIZED_BY_TERT_UP | 4.18e-07 | 88 | 45 | 5 | M5360 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP | 1.34e-06 | 13 | 45 | 3 | MM743 | |
| Coexpression | ZHANG_UTERUS_C0_SECRETORY_STROMAL3_NPPC_HIGH_CELL | 1.63e-06 | 337 | 45 | 7 | MM16606 | |
| Coexpression | HEVNER_TELENCEPHALON_MENINGEAL_CELLS | 1.65e-06 | 50 | 45 | 4 | MM403 | |
| Coexpression | AIZARANI_LIVER_C33_STELLATE_CELLS_2 | 2.48e-06 | 126 | 45 | 5 | M39132 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 3.79e-06 | 18 | 45 | 3 | M47984 | |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | 3.92e-06 | 385 | 45 | 7 | M39264 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 4.31e-06 | 141 | 45 | 5 | M10381 | |
| Coexpression | CUI_DEVELOPING_HEART_COMPACT_VENTRICULAR_CARDIOMYOCYTE | 4.75e-06 | 65 | 45 | 4 | M39309 | |
| Coexpression | CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_DN | 5.11e-06 | 146 | 45 | 5 | MM973 | |
| Coexpression | JAEGER_METASTASIS_DN | 5.30e-06 | 260 | 45 | 6 | M10702 | |
| Coexpression | DESCARTES_FETAL_STOMACH_SQUAMOUS_EPITHELIAL_CELLS | 5.37e-06 | 67 | 45 | 4 | M40299 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 5.64e-06 | 149 | 45 | 5 | M45703 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 7.45e-06 | 276 | 45 | 6 | M3063 | |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP | 7.99e-06 | 74 | 45 | 4 | M515 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 7.99e-06 | 74 | 45 | 4 | M13547 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_BONE_DN | 1.85e-05 | 324 | 45 | 6 | M2700 | |
| Coexpression | SIMBULAN_PARP1_TARGETS_UP | 1.86e-05 | 30 | 45 | 3 | M1550 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 1.95e-05 | 493 | 45 | 7 | M19391 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_PROXIMAL_BASAL_CELL | 1.98e-05 | 193 | 45 | 5 | M45706 | |
| Coexpression | SIMBULAN_PARP1_TARGETS_UP | 2.06e-05 | 31 | 45 | 3 | MM665 | |
| Coexpression | GSE18148_CBFB_KO_VS_WT_TREG_DN | 2.35e-05 | 200 | 45 | 5 | M4252 | |
| Coexpression | GSE13306_RA_VS_UNTREATED_TCONV_UP | 2.35e-05 | 200 | 45 | 5 | M3234 | |
| Coexpression | ROZANOV_MMP14_TARGETS_SUBSET | 2.49e-05 | 33 | 45 | 3 | M9167 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 2.98e-05 | 35 | 45 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 3.24e-05 | 36 | 45 | 3 | MM1212 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 4.30e-05 | 6 | 45 | 2 | M48000 | |
| Coexpression | GU_PDEF_TARGETS_DN | 4.47e-05 | 40 | 45 | 3 | M10480 | |
| Coexpression | ZHANG_UTERUS_C2_SECRETORY_STROMAL3_RAMP3_HIGH_CELL | 4.48e-05 | 229 | 45 | 5 | MM16607 | |
| Coexpression | VALK_AML_WITH_FLT3_ITD | 4.82e-05 | 41 | 45 | 3 | M10010 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 4.88e-05 | 117 | 45 | 4 | M39300 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_AT1_CELL | 5.18e-05 | 42 | 45 | 3 | M45688 | |
| Coexpression | FOROUTAN_INTEGRATED_TGFB_EMT_UP | 5.38e-05 | 120 | 45 | 4 | M42505 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 6.31e-05 | 125 | 45 | 4 | M1969 | |
| Coexpression | ONDER_CDH1_TARGETS_2_UP | 7.73e-05 | 257 | 45 | 5 | M13867 | |
| Coexpression | MIKKELSEN_IPS_ICP_WITH_H3K4ME3_AND_H327ME3 | 7.80e-05 | 132 | 45 | 4 | MM841 | |
| Coexpression | CHIBA_RESPONSE_TO_TSA_UP | 8.76e-05 | 50 | 45 | 3 | M10372 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 9.01e-05 | 137 | 45 | 4 | M40313 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 9.82e-05 | 1115 | 45 | 9 | M10371 | |
| Coexpression | GSE37605_TREG_VS_TCONV_NOD_FOXP3_FUSION_GFP_UP | 1.28e-04 | 150 | 45 | 4 | M8796 | |
| Coexpression | AMIT_SERUM_RESPONSE_240_MCF10A | 1.30e-04 | 57 | 45 | 3 | M2777 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | 1.40e-04 | 909 | 45 | 8 | M41018 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 1.49e-04 | 681 | 45 | 7 | M39175 | |
| Coexpression | LEE_LIVER_CANCER_DENA_UP | 1.51e-04 | 60 | 45 | 3 | M16524 | |
| Coexpression | BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP | 1.57e-04 | 299 | 45 | 5 | M34002 | |
| Coexpression | PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN | 1.72e-04 | 162 | 45 | 4 | M1459 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 1.83e-04 | 64 | 45 | 3 | M2572 | |
| Coexpression | ZHANG_UTERUS_C1_PROLIFERATIVE_STROMAL1_MGP_HIGH_CELL | 1.86e-04 | 310 | 45 | 5 | MM16608 | |
| Coexpression | JI_CARCINOGENESIS_BY_KRAS_AND_STK11_UP | 1.88e-04 | 12 | 45 | 2 | M1769 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA_TUMOR_CELL_DERIVED | 1.88e-04 | 12 | 45 | 2 | M47983 | |
| Coexpression | DESCARTES_FETAL_LIVER_MESOTHELIAL_CELLS | 1.94e-04 | 313 | 45 | 5 | M40228 | |
| Coexpression | GSE13547_CTRL_VS_ANTI_IGM_STIM_BCELL_2H_DN | 1.98e-04 | 168 | 45 | 4 | M2991 | |
| Coexpression | DESCARTES_ORGANOGENESIS_MELANOCYTES | 2.01e-04 | 66 | 45 | 3 | MM3664 | |
| Coexpression | FAN_OVARY_CL5_HEALTHY_SELECTABLE_FOLLICLE_THECAL_CELL | 2.09e-04 | 318 | 45 | 5 | M41707 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_DUCTAL_NORMAL_UP | 2.29e-04 | 69 | 45 | 3 | M10165 | |
| Coexpression | ANDERSEN_CHOLANGIOCARCINOMA_CLASS2 | 2.31e-04 | 175 | 45 | 4 | M246 | |
| Coexpression | LI_AMPLIFIED_IN_LUNG_CANCER | 2.74e-04 | 183 | 45 | 4 | M5792 | |
| Coexpression | FOROUTAN_PRODRANK_TGFB_EMT_UP | 2.85e-04 | 185 | 45 | 4 | M42503 | |
| Coexpression | BRUECKNER_TARGETS_OF_MIRLET7A3_DN | 3.05e-04 | 76 | 45 | 3 | M11825 | |
| Coexpression | FOROUTAN_TGFB_EMT_UP | 3.29e-04 | 192 | 45 | 4 | M42501 | |
| Coexpression | PRC2_EZH2_UP.V1_UP | 3.29e-04 | 192 | 45 | 4 | M2739 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 3.34e-04 | 352 | 45 | 5 | M17471 | |
| Coexpression | MACLACHLAN_BRCA1_TARGETS_DN | 3.41e-04 | 16 | 45 | 2 | M10593 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 3.41e-04 | 79 | 45 | 3 | M18400 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 3.42e-04 | 194 | 45 | 4 | M39122 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_16 | 3.54e-04 | 80 | 45 | 3 | MM1285 | |
| Coexpression | GSE21546_WT_VS_ELK1_KO_DP_THYMOCYTES_UP | 3.76e-04 | 199 | 45 | 4 | M7520 | |
| Coexpression | GSE22601_DOUBLE_NEGATIVE_VS_CD8_SINGLE_POSITIVE_THYMOCYTE_UP | 3.76e-04 | 199 | 45 | 4 | M6235 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_MATURE_NEURON_CELL_LINE_UP | 3.76e-04 | 199 | 45 | 4 | M7420 | |
| Coexpression | DOUGLAS_BMI1_TARGETS_UP | 3.82e-04 | 563 | 45 | 6 | M15103 | |
| Coexpression | GSE8835_HEALTHY_VS_CLL_CD4_TCELL_DN | 3.84e-04 | 200 | 45 | 4 | M6261 | |
| Coexpression | GSE17721_LPS_VS_CPG_0.5H_BMDC_DN | 3.84e-04 | 200 | 45 | 4 | M3983 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_DN | 3.84e-04 | 200 | 45 | 4 | M9654 | |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_DN | 3.84e-04 | 200 | 45 | 4 | M3575 | |
| Coexpression | GSE17721_PAM3CSK4_VS_CPG_16H_BMDC_UP | 3.84e-04 | 200 | 45 | 4 | M3869 | |
| Coexpression | GSE27434_WT_VS_DNMT1_KO_TREG_UP | 3.84e-04 | 200 | 45 | 4 | M9620 | |
| Coexpression | GSE1460_INTRATHYMIC_T_PROGENITOR_VS_THYMIC_STROMAL_CELL_DN | 3.84e-04 | 200 | 45 | 4 | M3450 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.86e-04 | 17 | 45 | 2 | M2223 | |
| Coexpression | KANG_AR_TARGETS_UP | 3.86e-04 | 17 | 45 | 2 | MM1297 | |
| Coexpression | NGUYEN_NOTCH1_TARGETS_DN | 3.95e-04 | 83 | 45 | 3 | M14650 | |
| Coexpression | BROWNE_HCMV_INFECTION_16HR_DN | 3.95e-04 | 83 | 45 | 3 | M19130 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 3.95e-04 | 83 | 45 | 3 | M2448 | |
| Coexpression | ZENG_GU_POST_ICB_METAGENE_39 | 4.13e-04 | 204 | 45 | 4 | MM17090 | |
| Coexpression | ZHANG_UTERUS_C4_MYOFIBROBLAST | 4.14e-04 | 369 | 45 | 5 | MM16610 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 4.33e-04 | 18 | 45 | 2 | M13796 | |
| Coexpression | THUM_MIR21_TARGETS_HEART_DISEASE_UP | 4.33e-04 | 18 | 45 | 2 | MM1241 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | COL4A2 COL4A5 COL4A6 COL5A1 KRT5 KRT6A COL8A1 FBN2 COL13A1 ITGA5 DUSP8 SSUH2 BAHCC1 | 7.52e-08 | 982 | 45 | 13 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | Mesoderm Day 5_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A2 COL4A5 COL4A6 COL5A1 COL6A2 FBN2 COL13A1 MAGED1 ITGA5 ARHGEF17 DUSP8 BAHCC1 ZBTB22 | 4.78e-07 | 1153 | 45 | 13 | PCBC_ratio_MESO-5_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500 | 7.18e-07 | 489 | 45 | 9 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | LAMA5 COL24A1 KRT5 COL6A2 COL7A1 COL8A1 ELN BCL11B SLC7A3 EBF4 COL1A2 | 4.41e-06 | 976 | 45 | 11 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | COL4A4 COL4A5 COL4A6 COL5A1 COL6A2 COL8A1 ELN FBN2 COL13A1 COL1A2 | 4.70e-06 | 790 | 45 | 10 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500_k-means-cluster#4 | 7.36e-06 | 59 | 45 | 4 | Arv_EB-LF_500_K4 | |
| CoexpressionAtlas | BM Top 100 - endometrium | 1.15e-05 | 66 | 45 | 4 | BM Top 100 - endometrium | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.20e-05 | 371 | 45 | 7 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#3 | 1.36e-05 | 249 | 45 | 6 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K3 | |
| CoexpressionAtlas | BM Top 100 - mammary gland | 1.82e-05 | 74 | 45 | 4 | BM Top 100 - mammary gland | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.93e-05 | 265 | 45 | 6 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000_K1 | |
| CoexpressionAtlas | BM Top 100 - vagina | 2.02e-05 | 76 | 45 | 4 | BM Top 100 - vagina | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.43e-05 | 276 | 45 | 6 | Facebase_RNAseq_e10.5_Olfactory Pit_1000_K5 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#4_top-relative-expression-ranked_200 | 2.51e-05 | 27 | 45 | 3 | gudmap_developingGonad_e18.5_epididymis_200_k4 | |
| CoexpressionAtlas | Mesoderm Day 5-reprogram_OSKM-L_vs_Mesoderm Day 5-reprogram_NA-Confounder_removed-fold2.0_adjp0.05 | 2.69e-05 | 281 | 45 | 6 | PCBC_ratio_MESO-5_from-OSKM-L_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 5-method_mRNA_vs_Mesoderm Day 5-method_NA-Confounder_removed-fold2.0_adjp0.05 | 2.69e-05 | 281 | 45 | 6 | PCBC_ratio_MESO-5_from-mRNA_vs_MESO-5_from-ESC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000 | COL24A1 KRT5 COL6A2 COL7A1 COL8A1 ELN BCL11B TAS1R3 EBF4 COL1A2 | 2.73e-05 | 967 | 45 | 10 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000 | CELF5 COL24A1 KRT5 KRT6A COL7A1 COL8A1 BCL11B COL13A1 COL1A2 | 2.81e-05 | 769 | 45 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | RBM42 COL24A1 KRT5 COL6A2 COL7A1 COL8A1 ELN BCL11B EBF4 COL1A2 | 2.85e-05 | 972 | 45 | 10 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | ratio_induced-DefinitiveEndoderm_vs_StemCell_top-relative-expression-ranked_1000 | COL4A6 COL5A1 KRT5 COL6A2 COL8A1 FBN2 COL13A1 ITGA5 SSUH2 BAHCC1 | 2.95e-05 | 976 | 45 | 10 | PCBC_ratio_DE_vs_SC_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000 | BHLHE41 CELF5 COL5A1 COL24A1 KRT5 KRT6A KRT6B KRT6C EBF4 COL1A2 | 3.09e-05 | 981 | 45 | 10 | Arv_EB-LF_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_1000 | LAMA5 COL24A1 KRT5 COL6A2 COL7A1 COL8A1 ELN BCL11B EBF4 COL1A2 | 3.17e-05 | 984 | 45 | 10 | Facebase_RNAseq_e10.5_Olfactory Pit_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.73e-05 | 298 | 45 | 6 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K4 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | COL4A2 COL4A5 COL4A6 COL7A1 FBN2 MAGED1 ITGA5 ARHGEF17 C19orf12 BAHCC1 COL1A2 ZBTB22 | 3.80e-05 | 1466 | 45 | 12 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | EB cord blood_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 3.95e-05 | 181 | 45 | 5 | PCBC_ratio_EB cord blood_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 4.32e-05 | 453 | 45 | 7 | GSM777067_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_SmallAirwayEpithel_top-relative-expression-ranked_100 | 5.50e-05 | 98 | 45 | 4 | PCBC_ctl_SmallAirwayEpithel_100 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_BronchioEpithel_top-relative-expression-ranked_100 | 5.50e-05 | 98 | 45 | 4 | PCBC_ctl_BronchioEpithel_100 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.90e-05 | 197 | 45 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#3 | 6.05e-05 | 325 | 45 | 6 | Arv_EB-LF_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500 | 6.15e-05 | 479 | 45 | 7 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_500 | 7.65e-05 | 496 | 45 | 7 | Arv_EB-LF_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.33e-04 | 123 | 45 | 4 | gudmap_developingGonad_e16.5_epididymis_1000_k3 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.33e-04 | 123 | 45 | 4 | Arv_EB-LF_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.51e-04 | 384 | 45 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.61e-04 | 244 | 45 | 5 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 1.64e-04 | 967 | 45 | 9 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | 1.64e-04 | 967 | 45 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | 1.65e-04 | 968 | 45 | 9 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | 1.72e-04 | 973 | 45 | 9 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | 1.73e-04 | 974 | 45 | 9 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | 1.74e-04 | 761 | 45 | 8 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000 | 1.78e-04 | 978 | 45 | 9 | Facebase_RNAseq_e10.5_Mandibular Arch_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.13e-04 | 139 | 45 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#5_top-relative-expression-ranked_1000 | 2.25e-04 | 141 | 45 | 4 | gudmap_developingGonad_P2_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | 2.39e-04 | 797 | 45 | 8 | gudmap_developingGonad_P2_epididymis_1000 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | 2.43e-04 | 799 | 45 | 8 | gudmap_developingGonad_e18.5_epididymis_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle M_emap-6706_top-relative-expression-ranked_500 | 2.75e-04 | 429 | 45 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle M_500 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#1 | 2.99e-04 | 152 | 45 | 4 | ratio_MESO_vs_SC_1000_K1 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 3.03e-04 | 437 | 45 | 6 | GSM777046_500 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#2_top-relative-expression-ranked_500 | 3.39e-04 | 64 | 45 | 3 | gudmap_developingGonad_e18.5_epididymis_500_k2 | |
| CoexpressionAtlas | BM Top 100 - cervix | 3.71e-04 | 66 | 45 | 3 | BM Top 100 - cervix | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#3 | 4.18e-04 | 166 | 45 | 4 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 4.18e-04 | 166 | 45 | 4 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | BM Top 100 - saphenous vein | 4.23e-04 | 69 | 45 | 3 | BM Top 100 - saphenous vein | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 4.27e-04 | 466 | 45 | 6 | GSM777050_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_emap-30875_top-relative-expression-ranked_200 | 4.37e-04 | 168 | 45 | 4 | gudmap_developingLowerUrinaryTract_e13.5_bladder neck-urethr epithel_200 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue | 4.41e-04 | 70 | 45 | 3 | BM Top 100 - adipose tissue | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_100 | 4.53e-04 | 15 | 45 | 2 | gudmap_developingGonad_P2_epididymis_100_k1 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#1_top-relative-expression-ranked_500 | 4.60e-04 | 71 | 45 | 3 | gudmap_developingGonad_P2_epididymis_500_k1 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue subcutaneous | 4.79e-04 | 72 | 45 | 3 | BM Top 100 - adipose tissue subcutaneous | |
| CoexpressionAtlas | BM Top 100 - coronary artery | 4.99e-04 | 73 | 45 | 3 | BM Top 100 - coronary artery | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000_k-means-cluster#5 | 4.99e-04 | 480 | 45 | 6 | ratio_MESO_vs_SC_1000_K5 | |
| CoexpressionAtlas | BM Top 100 - adipose tissue omental | 5.19e-04 | 74 | 45 | 3 | BM Top 100 - adipose tissue omental | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500 | 5.33e-04 | 486 | 45 | 6 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_500 | 5.44e-04 | 488 | 45 | 6 | Facebase_RNAseq_ratio_e9.5_MaxillaryArch_vs_Mandibular_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_500 | 5.74e-04 | 493 | 45 | 6 | PCBC_ctl_CardiacMyocyte_500 | |
| CoexpressionAtlas | BM Top 100 - urethra | 5.83e-04 | 77 | 45 | 3 | BM Top 100 - urethra | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_500 | 5.86e-04 | 495 | 45 | 6 | PCBC_ratio_MESO-5_vs_SC_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_100 | 6.05e-04 | 78 | 45 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_100 | |
| CoexpressionAtlas | BM Top 100 - tongue superior part w_papillae | 6.28e-04 | 79 | 45 | 3 | BM Top 100 - tongue superior part w_papillae | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_1000_k-means-cluster#2 | 6.45e-04 | 330 | 45 | 5 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_1000_K2 | |
| CoexpressionAtlas | BM Top 100 - tongue main corpus | 6.52e-04 | 80 | 45 | 3 | BM Top 100 - tongue main corpus | |
| CoexpressionAtlas | BM Top 100 - nipple cross-section | 7.52e-04 | 84 | 45 | 3 | BM Top 100 - nipple cross-section | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | 7.75e-04 | 951 | 45 | 8 | Arv_EB-LF_2500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_top-relative-expression-ranked_100 | 7.78e-04 | 85 | 45 | 3 | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle F_emap-6706_100 | |
| CoexpressionAtlas | BM Top 100 - esophagus | 8.05e-04 | 86 | 45 | 3 | BM Top 100 - esophagus | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | 8.99e-04 | 973 | 45 | 8 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | 9.11e-04 | 975 | 45 | 8 | PCBC_ctl_CardiacMyocyte_1000 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_500 | 9.39e-04 | 206 | 45 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_500_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#1_top-relative-expression-ranked_500 | 9.79e-04 | 92 | 45 | 3 | gudmap_developingGonad_e16.5_epididymis_500_k1 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_500_k-means-cluster#4 | 9.79e-04 | 92 | 45 | 3 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_500_K4 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_ureteral tissue_emap-8234_k-means-cluster#3_top-relative-expression-ranked_1000 | 9.79e-04 | 92 | 45 | 3 | gudmap_developingLowerUrinaryTract_e15.5_ureteral tissue_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_testes_emap-11164_k-means-cluster#3_top-relative-expression-ranked_500 | 1.04e-03 | 94 | 45 | 3 | gudmap_developingGonad_e18.5_testes_500_k3 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | 1.07e-03 | 95 | 45 | 3 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.08e-03 | 214 | 45 | 4 | gudmap_developingGonad_e16.5_testes_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_1000 | 1.13e-03 | 774 | 45 | 7 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_B | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.17e-03 | 377 | 45 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k2 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_100 | 1.18e-03 | 98 | 45 | 3 | Arv_EB-LF_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.18e-03 | 24 | 45 | 2 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.20e-03 | 379 | 45 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_B_1000_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_500 | 1.27e-03 | 384 | 45 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_500_B | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_500 | 1.32e-03 | 387 | 45 | 5 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Paraxial Mesoderm_top-relative-expression-ranked_500_k-means-cluster#2 | 1.36e-03 | 103 | 45 | 3 | Facebase_RNAseq_e8.5_Paraxial Mesoderm_500_K2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_500 | 1.36e-03 | 390 | 45 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_500 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K2 | 1.39e-03 | 1298 | 45 | 9 | gudmap_RNAseq_e15.5_Mesangium_2500_K2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 1.44e-03 | 395 | 45 | 5 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4 | 1.47e-03 | 591 | 45 | 6 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.50e-03 | 234 | 45 | 4 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.50e-03 | 234 | 45 | 4 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.68e-13 | 180 | 45 | 9 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | COL4A2 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 ELN TAS1R3 COL1A2 | 2.49e-13 | 188 | 45 | 9 | b382d18fb09fb2869f3c151efa71540a7f5ed229 |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | COL4A2 COL4A3 COL4A4 COL5A1 COL24A1 COL6A2 COL8A1 ELN COL1A2 | 3.02e-13 | 192 | 45 | 9 | 356160b113c3305a61ceeaff33ce3c9da0be2878 |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.45e-11 | 187 | 45 | 8 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.51e-11 | 188 | 45 | 8 | 997dcfc4f08738ab398d8abc15e4fd2fc6619862 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 1.86e-11 | 193 | 45 | 8 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 1.94e-11 | 194 | 45 | 8 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 2.03e-11 | 195 | 45 | 8 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-11 | 197 | 45 | 8 | 1da8ba5bbab232add6e43ad78b15c2339d0c2bc3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.20e-11 | 197 | 45 | 8 | 467e7cbf511d3bcc701923603032aaf0bba2736d | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-11 | 198 | 45 | 8 | b086af292a508a156266c2d899ba1caf820bf61c | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.29e-11 | 198 | 45 | 8 | 524305c5d7b1d53e86ec0af775efefa3e0955e47 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.38e-11 | 199 | 45 | 8 | e78f661b40da34768469549b6e755d330be6bbd8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-Pericyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.07e-10 | 171 | 45 | 7 | a4a2c5dc995589fbe3d4ca6ee1df888807e4ae34 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.60e-10 | 179 | 45 | 7 | a1ea8daa0fe8900f5a04b555c77fe8ebdaa3908d | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 5.60e-10 | 179 | 45 | 7 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 6.54e-10 | 183 | 45 | 7 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|normal_Lung / Location, Cell class and cell subclass | 6.79e-10 | 184 | 45 | 7 | 0b336489c10e8c3c957795dd845454f03404382b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-3|TCGA-Lung / Sample_Type by Project: Shred V9 | 6.79e-10 | 184 | 45 | 7 | ea4ccebe2d54279fcc517e4f0bfa652b91a808bb | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.79e-10 | 184 | 45 | 7 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.60e-10 | 187 | 45 | 7 | ed7ab4cf4629d96dad5c74d536fc428d0a8d4eb9 | |
| ToppCell | Mesenchymal-chondrocyte|World / Lineage, Cell type, age group and donor | 7.89e-10 | 188 | 45 | 7 | 7b1e3f8a941eaa68e89c562129a92314642eec66 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-Airway_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 8.19e-10 | 189 | 45 | 7 | 4f9608b84d135268a17455661870c46ae8554a24 | |
| ToppCell | MatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4) | 8.49e-10 | 190 | 45 | 7 | d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 8.49e-10 | 190 | 45 | 7 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.14e-10 | 192 | 45 | 7 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 9.82e-10 | 194 | 45 | 7 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.82e-10 | 194 | 45 | 7 | 735eee6ef25589f935fa922788ebbdbfef61249e | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 9.82e-10 | 194 | 45 | 7 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 1.02e-09 | 195 | 45 | 7 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-D|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-09 | 195 | 45 | 7 | 78cfde21dde4b877fc76c8b0d5ddaabe44b912d7 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.02e-09 | 195 | 45 | 7 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | RA-02._Fibroblast_II|RA / Chamber and Cluster_Paper | 1.02e-09 | 195 | 45 | 7 | 6a02ebbeb3199447ddce64d92d8809436e040eba | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.02e-09 | 195 | 45 | 7 | fee9d13f48149cd5f921cfe4b8b3053cf6a6dbd2 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.05e-09 | 196 | 45 | 7 | 1f47916c2663bd88c1e7c19c6a7688f4c7173ad2 | |
| ToppCell | RA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.05e-09 | 196 | 45 | 7 | e8cbda03837f1f26470a9d93aa7fdaa04e08e38a | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.09e-09 | 197 | 45 | 7 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-09 | 198 | 45 | 7 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.13e-09 | 198 | 45 | 7 | 8b9e8eaeffda40912a0163fdf39b93bc5e64751c | |
| ToppCell | Epithelial_cells-Basal_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.13e-09 | 198 | 45 | 7 | 4235005c49fc2b29ad3a0ee6b608f0109d04f775 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-09 | 198 | 45 | 7 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-09 | 198 | 45 | 7 | d83707b69fb64721ac3cff90ba58cdd999d6b386 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-09 | 198 | 45 | 7 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-09 | 198 | 45 | 7 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | Fetal_29-31_weeks|World / Lineage, Cell type, age group and donor | 1.17e-09 | 199 | 45 | 7 | 5b9d355795dd03a22f0961dfd143425c367a4654 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-09 | 199 | 45 | 7 | 94a7867e800df352731796de8c24cba133c29622 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_2_(NPY+)|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-09 | 199 | 45 | 7 | ec74ff85d6b61013b1f785b2fca343759feb7843 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-09 | 199 | 45 | 7 | edba1833ef5c4ca122d7c32f97670314e005f93b | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-09 | 199 | 45 | 7 | 8d71e1fc92ee24deedf23fbb1a85a7fba0d8d436 | |
| ToppCell | ILEUM-inflamed-(8)_Activated_fibroblasts|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.17e-09 | 199 | 45 | 7 | 317f412996d463ddf2e6a52ff41d5d676c77f43f | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-09 | 199 | 45 | 7 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.17e-09 | 199 | 45 | 7 | 49690494270981eec5b5261c59e0545dff90cc21 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.21e-09 | 200 | 45 | 7 | 07641f476cb1a131c2a50258b88cc13bb38c8379 | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-3|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.21e-09 | 200 | 45 | 7 | 343fa6ba1f52d816d2e41466f674ff8360aecd81 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-3-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.21e-09 | 200 | 45 | 7 | d0c00cdd52c2e001aec9b935f4e981ba77d0386a | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.02e-08 | 153 | 45 | 6 | e9c6fb5c41adb6595c66c3a917fe455348279e54 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.02e-08 | 153 | 45 | 6 | b8b5ff7d2feea3e3a352fb5530e49f639fe1ff88 | |
| ToppCell | Thalamus-Endothelial-ENDOTHELIAL_TIP|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.02e-08 | 153 | 45 | 6 | 2513edfae62a44e51d3556675a096723194c966c | |
| ToppCell | Adult-Mesenchymal-vascular_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 1.24e-08 | 158 | 45 | 6 | 8d64c0c9de910a3f4658778642d183c8b9b6f6a2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.24e-08 | 158 | 45 | 6 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-08 | 159 | 45 | 6 | e812cbde59188924c6277c3feadf1a9592fa62a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.29e-08 | 159 | 45 | 6 | 2607b562903228274fbd96168ba826782fab0b53 | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 1.29e-08 | 159 | 45 | 6 | 92049a8d8fc9997d8d0d76500c72596a9b2394e0 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 1.55e-08 | 164 | 45 | 6 | de1646dbcf2a10b48e021acf7dc63e803e6a47ce | |
| ToppCell | normal_Lung-Fibroblasts-Myofibroblasts|Fibroblasts / Location, Cell class and cell subclass | 1.55e-08 | 164 | 45 | 6 | 9b4a6007abae992db871d9f6f731d5af724de30d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.85e-08 | 169 | 45 | 6 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 1.85e-08 | 169 | 45 | 6 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.13e-08 | 173 | 45 | 6 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-08 | 176 | 45 | 6 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-08 | 176 | 45 | 6 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-08 | 177 | 45 | 6 | 9ec7f1e64312d26d434b3312b58386715dbad644 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-08 | 177 | 45 | 6 | 016277dfd59b1793fddaaadc2b3f41622d76ce3a | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.70e-08 | 180 | 45 | 6 | f2f6e83127a4a415e65c76a35efa8175fbd5b5d9 | |
| ToppCell | RA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.79e-08 | 181 | 45 | 6 | 2b6ddeb53a79a658e2ba78527ff48c155b20daa6 | |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 2.79e-08 | 181 | 45 | 6 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.88e-08 | 182 | 45 | 6 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-08 | 183 | 45 | 6 | 803376f5260de83c48d4f7301278d078a32b3e6e | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-08 | 183 | 45 | 6 | 6d98973098c6d20c5305bce6a83a549a7d8dbfba | |
| ToppCell | 5'-Airway_Nasal-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.98e-08 | 183 | 45 | 6 | cc7f5a17b40e8d901885174922e5fa8877643071 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.08e-08 | 184 | 45 | 6 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | droplet-Lung-1m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l1|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.08e-08 | 184 | 45 | 6 | e33e2a887aafba7b6a31f00bb0dbe974b4359fd6 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 3.08e-08 | 184 | 45 | 6 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.08e-08 | 184 | 45 | 6 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.18e-08 | 185 | 45 | 6 | 1c222f7285d6e3dae0354dc7e853ddc0ea55e63e | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.18e-08 | 185 | 45 | 6 | 7dcdc009c5681ee05dd18968f7e85c3403fe34af | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_2_(CH25H+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.28e-08 | 186 | 45 | 6 | 360c3e9e5c3a943e68e6939b4a47821bfc75b553 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.39e-08 | 187 | 45 | 6 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.39e-08 | 187 | 45 | 6 | 13731298bc562ec29582f5da1b4c97261284f6f1 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.39e-08 | 187 | 45 | 6 | d4b0afd9b92c47c8aa348bbd1af7eb54c3d478f2 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1|Adult / Lineage, Cell type, age group and donor | 3.39e-08 | 187 | 45 | 6 | 77f78aec946bc6bd85c29aee9ca978ce49f853a3 | |
| ToppCell | Pericytes-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.50e-08 | 188 | 45 | 6 | f16ff998393bf1954bbf10caab15173bdb104ac1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.50e-08 | 188 | 45 | 6 | ce85a56ac27a6432421dde93a1bafa8b943244b9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_1-GABA_L1_LAMP5-Inh_L5-6_LAMP5_SFTA3_(Lamp5_Lhx6_2)|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.50e-08 | 188 | 45 | 6 | 4544552ebd67e9eb3e40d8511bb2b03a6e1178f8 | |
| ToppCell | facs-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-08 | 188 | 45 | 6 | bba6b273bd47dd0e27fde914e9e6fc9d76fd5176 | |
| ToppCell | Mesenchymal-myofibroblast_cell|World / Lineage, Cell type, age group and donor | 3.61e-08 | 189 | 45 | 6 | 44e37f88137bb249933eb615235b2cf2ae7f3925 | |
| ToppCell | E18.5-samps-Mesenchymal|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.61e-08 | 189 | 45 | 6 | 0c18d3de4720759cf802eefb4d0ddde2a9246a1a | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D231|Adult / Lineage, Cell type, age group and donor | 3.61e-08 | 189 | 45 | 6 | 5a04cb25f8f0447b2cecdb6c3695029281aca26d | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 3.61e-08 | 189 | 45 | 6 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | IPF-Epithelial-Basal|IPF / Disease state, Lineage and Cell class | 3.72e-08 | 190 | 45 | 6 | ea19e9ce954f2dfde97388db9695325cd92ab88f | |
| ToppCell | Mesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor | 3.72e-08 | 190 | 45 | 6 | 645e56b02edc3702c7db917b8ecd5eed0decaf71 | |
| Computational | Adhesion molecules. | 2.44e-09 | 141 | 29 | 8 | MODULE_122 | |
| Computational | Genes in the cancer module 153. | 1.87e-06 | 34 | 29 | 4 | MODULE_153 | |
| Computational | Genes in the cancer module 297. | 2.08e-06 | 80 | 29 | 5 | MODULE_297 | |
| Computational | Intermediate filaments and keratins. | 2.08e-06 | 80 | 29 | 5 | MODULE_357 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.03e-06 | 50 | 29 | 4 | GAVISH_3CA_METAPROGRAM_FIBROBLASTS_CAF_1 | |
| Computational | Intermediate filaments and MT. | 3.09e-05 | 68 | 29 | 4 | MODULE_438 | |
| Computational | Neighborhood of CDH11 | 3.90e-05 | 25 | 29 | 3 | GNF2_CDH11 | |
| Computational | Keratin. | 4.40e-05 | 26 | 29 | 3 | MODULE_298 | |
| Computational | Genes in the cancer module 68. | 4.40e-05 | 26 | 29 | 3 | MODULE_68 | |
| Computational | Intermediate filaments. | 4.55e-05 | 75 | 29 | 4 | MODULE_154 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.18e-04 | 50 | 29 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.18e-04 | 50 | 29 | 3 | GAVISH_3CA_MALIGNANT_METAPROGRAM_12_EMT_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.18e-04 | 50 | 29 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Computational | Placenta genes. | 1.26e-03 | 463 | 29 | 6 | MODULE_38 | |
| Computational | Spinal cord (neuro-development) genes. | 2.51e-03 | 360 | 29 | 5 | MODULE_12 | |
| Computational | Neighborhood of PTX3 | 4.18e-03 | 36 | 29 | 2 | GNF2_PTX3 | |
| Drug | AC1LAKND | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 ITGA5 COL1A2 | 1.44e-21 | 62 | 45 | 12 | CID000470146 |
| Drug | pirfenidone | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 KRT6A KRT6B COL7A1 COL8A1 COL11A2 COL13A1 KRT6C COL1A2 | 6.53e-21 | 138 | 45 | 14 | CID000040632 |
| Drug | BAPN | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 COL13A1 COL1A2 | 8.42e-21 | 71 | 45 | 12 | CID000001647 |
| Drug | GK-101 | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 7.60e-20 | 36 | 45 | 10 | CID000161853 |
| Drug | halofuginone lactate | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ASPSCR1 COL11A2 COL13A1 COL1A2 | 8.49e-20 | 85 | 45 | 12 | CID000062891 |
| Drug | 4-hydroxyproline | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 COL13A1 COL1A2 | 2.02e-19 | 91 | 45 | 12 | CID000000825 |
| Drug | Madecassol | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 1.20e-18 | 46 | 45 | 10 | CID000108062 |
| Drug | hydroxylysine | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 COL13A1 COL1A2 | 1.96e-18 | 109 | 45 | 12 | CID000001029 |
| Drug | AC1L1C2F | COL4A3 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 ITGA5 COL1A2 | 2.20e-18 | 110 | 45 | 12 | CID000001711 |
| Drug | d-indobufen | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 3.01e-18 | 50 | 45 | 10 | CID000044562 |
| Drug | ridogrel | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 4.62e-18 | 52 | 45 | 10 | CID005362391 |
| Drug | NSC49633 | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 5.69e-18 | 53 | 45 | 10 | CID000023340 |
| Drug | DL-penicillamine | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 COL13A1 COL1A2 | 4.00e-17 | 139 | 45 | 12 | CID000004727 |
| Drug | hyaluronan | COL4A3 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 FBN2 COL13A1 COL1A2 | 6.45e-17 | 263 | 45 | 14 | CID000024759 |
| Drug | ticlopidine | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 8.38e-17 | 103 | 45 | 11 | CID000005472 |
| Drug | malotilate | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 1.31e-16 | 71 | 45 | 10 | CID000004006 |
| Drug | AC1NMZ1B | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 2.35e-16 | 75 | 45 | 10 | CID005034185 |
| Drug | Tranilast sodium | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 2.94e-16 | 115 | 45 | 11 | CID000005527 |
| Drug | strontium ranelate | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 3.09e-16 | 77 | 45 | 10 | CID006918182 |
| Drug | AC1L1DD6 | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 COL13A1 COL1A2 | 8.82e-16 | 179 | 45 | 12 | CID000002299 |
| Drug | DMSe | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 ELN COL11A2 COL13A1 COL1A2 | 1.40e-15 | 132 | 45 | 11 | CID000020796 |
| Drug | PCR 4099 | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 2.50e-15 | 139 | 45 | 11 | CID000002806 |
| Drug | losartan | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 KRT5 COL6A2 COL7A1 COL8A1 COL11A2 FBN2 COL13A1 ITGA5 COL1A2 | 9.96e-15 | 378 | 45 | 14 | CID000003961 |
| Drug | PPACK | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 1.67e-14 | 113 | 45 | 10 | CID003036757 |
| Drug | AC1L9732 | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 1.82e-14 | 114 | 45 | 10 | CID000439300 |
| Drug | khellin | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 2.52e-14 | 171 | 45 | 11 | CID000003828 |
| Drug | Selara | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 4.68e-14 | 125 | 45 | 10 | CID000150310 |
| Drug | 12(S)-hydroxyeicosatetraenoic acid | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 ITGA5 COL1A2 | 7.64e-14 | 189 | 45 | 11 | CID000001413 |
| Drug | candesartan cilexetil | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 2.11e-13 | 145 | 45 | 10 | CID000002540 |
| Drug | L-lysyl-L-lysyl-L-lysine | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 6.47e-13 | 162 | 45 | 10 | CID000072363 |
| Drug | AC1Q6PCP | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 6.60e-13 | 230 | 45 | 11 | CID000005267 |
| Drug | chondroitin sulfate | COL4A3 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 ELN COL11A2 COL13A1 COL1A2 | 8.23e-13 | 413 | 45 | 13 | CID000024766 |
| Drug | L-3,4-dehydroproline | 1.47e-12 | 73 | 45 | 8 | CID000094284 | |
| Drug | foscarnet | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 3.20e-12 | 190 | 45 | 10 | CID000003414 |
| Drug | AC1L1KMJ | COL4A3 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 ITGA5 COL1A2 | 4.92e-12 | 476 | 45 | 13 | CID000030956 |
| Drug | silibinin | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 6.79e-12 | 285 | 45 | 11 | CID000005213 |
| Drug | colchine | COL4A3 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 7.55e-12 | 383 | 45 | 12 | CID000002833 |
| Drug | (2s,5s)-5-Carboxymethylproline | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 ITGA5 COL1A2 | 1.93e-11 | 314 | 45 | 11 | CID000447989 |
| Drug | AC1L18QD | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 2.79e-11 | 325 | 45 | 11 | CID000000213 |
| Drug | isodesmosine | 4.48e-11 | 33 | 45 | 6 | CID000013811 | |
| Drug | prostacyclin sodium salt | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 4.85e-11 | 250 | 45 | 10 | CID000000159 |
| Drug | desmosine | 9.03e-10 | 53 | 45 | 6 | CID000025435 | |
| Drug | LMWH | COL4A3 LAMA5 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 ELN COL11A2 COL13A1 COL1A2 | 4.02e-09 | 663 | 45 | 12 | CID000000772 |
| Drug | aspirin | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 9.09e-09 | 563 | 45 | 11 | CID000002244 |
| Drug | Y-27632 | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL11A2 COL13A1 COL1A2 | 1.25e-08 | 444 | 45 | 10 | CID000005711 |
| Drug | Rgd Peptide | 2.02e-08 | 239 | 45 | 8 | CID000104802 | |
| Drug | Olux | 6.30e-08 | 20 | 45 | 4 | CID000032797 | |
| Drug | kalinin | 7.75e-08 | 55 | 45 | 5 | CID000032518 | |
| Drug | SC-791 | 1.44e-07 | 6 | 45 | 3 | CID010291510 | |
| Drug | dermatan sulfate | 2.37e-07 | 220 | 45 | 7 | CID000032756 | |
| Drug | LS-63783 | COL4A3 COL4A5 COL4A6 COL5A1 COL24A1 COL6A2 COL7A1 COL8A1 COL11A2 COL13A1 COL1A2 | 3.37e-07 | 804 | 45 | 11 | CID000000231 |
| Drug | 1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one | 6.11e-07 | 373 | 45 | 8 | ctd:C540355 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 6.21e-07 | 83 | 45 | 5 | CID011968896 | |
| Drug | meticrane | 1.18e-06 | 11 | 45 | 3 | CID000004165 | |
| Drug | pyridinoline | 1.49e-06 | 99 | 45 | 5 | CID000105068 | |
| Drug | Fluorocurarine chloride [22273-09-2]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.39e-06 | 197 | 45 | 6 | 6083_UP | |
| Drug | NOC 18 | 3.97e-06 | 16 | 45 | 3 | ctd:C093285 | |
| Drug | DIMIT | 4.54e-06 | 56 | 45 | 4 | CID000006624 | |
| Drug | clobestasol propionate | 4.81e-06 | 17 | 45 | 3 | CID000002791 | |
| Drug | 2,3-pentanedione | 5.50e-06 | 129 | 45 | 5 | ctd:C013186 | |
| Drug | AC1L9INI | 5.60e-06 | 59 | 45 | 4 | CID000445839 | |
| Drug | sulfur mustard | 5.71e-06 | 130 | 45 | 5 | CID000010461 | |
| Drug | dithranol | 5.77e-06 | 18 | 45 | 3 | CID000002202 | |
| Drug | homocysteine thiolactone | 5.93e-06 | 131 | 45 | 5 | CID000107712 | |
| Drug | Spurr resin | 7.76e-06 | 64 | 45 | 4 | CID006449895 | |
| Drug | N1-acetylspermidine | 8.03e-06 | 20 | 45 | 3 | CID000000496 | |
| Drug | tert-butyl hydroperoxide | DIP2C LAMA5 COL4A5 COL5A1 COL6A2 COL7A1 ASPSCR1 COL13A1 ITGA5 COL1A2 | 8.18e-06 | 902 | 45 | 10 | CID000006410 |
| Drug | 4-aminoazobenzene | 8.77e-06 | 66 | 45 | 4 | CID000006051 | |
| Drug | CP-331 | 1.14e-05 | 3 | 45 | 2 | CID000130967 | |
| Drug | MK-6 | 1.42e-05 | 24 | 45 | 3 | CID005283547 | |
| Drug | Bhg-(2-1)fuc | 1.61e-05 | 25 | 45 | 3 | CID005287784 | |
| Drug | 4-hydroxytestosterone | 1.71e-05 | 78 | 45 | 4 | CID000160615 | |
| Drug | YIGSR | 1.80e-05 | 79 | 45 | 4 | CID000123977 | |
| Drug | 1-2q | 2.13e-05 | 289 | 45 | 6 | CID000011820 | |
| Drug | betamethasone valerate | 2.28e-05 | 28 | 45 | 3 | CID000016533 | |
| Drug | Brn 2557402 | 2.29e-05 | 4 | 45 | 2 | CID000042742 | |
| Drug | ethylnylestradiol | COL4A3 COL4A5 COL5A1 KRT5 KRT6A KRT6B COL7A1 ELN COL11A2 KRT6C COL1A2 | 2.37e-05 | 1251 | 45 | 11 | CID000003285 |
| Drug | KT 5823 | 2.82e-05 | 30 | 45 | 3 | ctd:C073601 | |
| Drug | 2-Formyl-Protoporphryn Ix | 3.12e-05 | 31 | 45 | 3 | CID011963946 | |
| Drug | 2-methoxy-N-(3-methyl-2-oxo-1,2,3,4-tetrahydroquinazolin-6-yl)benzenesulfonamide | 3.12e-05 | 31 | 45 | 3 | ctd:C577942 | |
| Drug | AGN 193109 | 3.12e-05 | 31 | 45 | 3 | CID000177238 | |
| Drug | sodium dodecyl sulfate | 3.14e-05 | 91 | 45 | 4 | CID000008778 | |
| Drug | 4,4'-thiodiphenol | 3.44e-05 | 32 | 45 | 3 | CID000017570 | |
| Drug | AC1L9MJT | 3.76e-05 | 192 | 45 | 5 | CID000448959 | |
| Drug | dimethylmalonimidate | 3.81e-05 | 5 | 45 | 2 | CID000189133 | |
| Drug | Cyclo-rgdphg | 3.81e-05 | 5 | 45 | 2 | CID006449872 | |
| Drug | retinoic acid; Down 200; 1uM; MCF7; HT_HG-U133A | 4.05e-05 | 195 | 45 | 5 | 5571_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 45 | 5 | 2225_DN | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; PC3; HT_HG-U133A | 4.25e-05 | 197 | 45 | 5 | 4295_DN | |
| Drug | Isopyrin hydrochloride [18342-39-7]; Down 200; 14.2uM; MCF7; HT_HG-U133A | 4.46e-05 | 199 | 45 | 5 | 6097_DN | |
| Drug | Sirius red | 4.52e-05 | 35 | 45 | 3 | CID005486818 | |
| Drug | N-Acetyl-L-leucine [1188-21-2]; Up 200; 23uM; MCF7; HT_HG-U133A | 4.57e-05 | 200 | 45 | 5 | 5683_UP | |
| Drug | Fursultiamine Hydrochloride [2105-43-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.57e-05 | 200 | 45 | 5 | 4975_UP | |
| Drug | chrysarobin | 5.35e-05 | 37 | 45 | 3 | CID000068111 | |
| Drug | tsuwabukinonol | 5.35e-05 | 37 | 45 | 3 | CID006440419 | |
| Drug | AC1L3XKP | 5.35e-05 | 37 | 45 | 3 | CID000123931 | |
| Drug | 4-fluoranylproline | 5.70e-05 | 6 | 45 | 2 | CID000450594 | |
| Drug | phenyl isocyanate | 5.70e-05 | 6 | 45 | 2 | ctd:C025319 | |
| Drug | Rgds Peptide | 5.71e-05 | 106 | 45 | 4 | CID000107775 | |
| Drug | CaLam | 6.27e-05 | 39 | 45 | 3 | CID004126474 | |
| Disease | collagen disease (implicated_via_orthology) | 2.11e-09 | 12 | 44 | 4 | DOID:854 (implicated_via_orthology) | |
| Disease | Alport syndrome | 3.09e-09 | 3 | 44 | 3 | cv:C1567741 | |
| Disease | Collagen IV-related nephropathies | 3.09e-09 | 3 | 44 | 3 | cv:CN076135 | |
| Disease | Hematuria, Benign Familial | 1.24e-08 | 4 | 44 | 3 | C0241908 | |
| Disease | Alport Syndrome | 1.24e-08 | 4 | 44 | 3 | C1567741 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 1.59e-08 | 53 | 44 | 5 | C4707243 | |
| Disease | Alport Syndrome, X-Linked | 3.09e-08 | 5 | 44 | 3 | C1567742 | |
| Disease | Alport Syndrome, Autosomal Dominant | 3.09e-08 | 5 | 44 | 3 | C1567743 | |
| Disease | Alport Syndrome, Autosomal Recessive | 3.09e-08 | 5 | 44 | 3 | C1567744 | |
| Disease | myopathy (implicated_via_orthology) | 7.97e-07 | 48 | 44 | 4 | DOID:423 (implicated_via_orthology) | |
| Disease | Leiomyomatosis, esophageal and vulval, with nephropathy | 2.17e-06 | 2 | 44 | 2 | C1839884 | |
| Disease | benign familial hematuria (is_implicated_in) | 2.17e-06 | 2 | 44 | 2 | DOID:0111365 (is_implicated_in) | |
| Disease | Alport syndrome, recessive type | 2.17e-06 | 2 | 44 | 2 | C2931254 | |
| Disease | Alport syndrome, dominant type | 2.17e-06 | 2 | 44 | 2 | C2931253 | |
| Disease | ALPORT SYNDROME 2, AUTOSOMAL RECESSIVE | 2.17e-06 | 2 | 44 | 2 | C4746745 | |
| Disease | autosomal recessive Alport syndrome (is_implicated_in) | 2.17e-06 | 2 | 44 | 2 | DOID:0110033 (is_implicated_in) | |
| Disease | Thin basement membrane disease | 2.17e-06 | 2 | 44 | 2 | C0403440 | |
| Disease | Benign familial hematuria | 2.17e-06 | 2 | 44 | 2 | cv:C0241908 | |
| Disease | Leiomyoma, Epithelioid | 2.17e-06 | 2 | 44 | 2 | C0086533 | |
| Disease | Renal glomerular disease | 5.37e-06 | 23 | 44 | 3 | C0268731 | |
| Disease | Glomerulopathy Assessment | 5.37e-06 | 23 | 44 | 3 | C4521256 | |
| Disease | Alport syndrome (is_implicated_in) | 6.51e-06 | 3 | 44 | 2 | DOID:10983 (is_implicated_in) | |
| Disease | autosomal recessive Alport syndrome (implicated_via_orthology) | 6.51e-06 | 3 | 44 | 2 | DOID:0110033 (implicated_via_orthology) | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 1.30e-05 | 4 | 44 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 1.30e-05 | 4 | 44 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | Pachyonychia congenita syndrome | 1.30e-05 | 4 | 44 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 1.30e-05 | 4 | 44 | 2 | C1721007 | |
| Disease | Early Pregnancy Loss | 2.13e-05 | 109 | 44 | 4 | C3830362 | |
| Disease | Miscarriage | 2.13e-05 | 109 | 44 | 4 | C4552766 | |
| Disease | Spontaneous abortion | 2.13e-05 | 109 | 44 | 4 | C0000786 | |
| Disease | Abortion, Tubal | 2.13e-05 | 109 | 44 | 4 | C0000822 | |
| Disease | Pachyonychia Congenita | 2.17e-05 | 5 | 44 | 2 | C0265334 | |
| Disease | hypertensive nephropathy | 3.25e-05 | 6 | 44 | 2 | C0848548 | |
| Disease | response to vaccine, cytokine measurement | 4.39e-05 | 131 | 44 | 4 | EFO_0004645, EFO_0004873 | |
| Disease | corneal resistance factor | 5.32e-05 | 451 | 44 | 6 | EFO_0010067 | |
| Disease | Hereditary hearing loss and deafness | 6.69e-05 | 146 | 44 | 4 | cv:C0236038 | |
| Disease | Ehlers-Danlos syndrome (is_implicated_in) | 7.77e-05 | 9 | 44 | 2 | DOID:13359 (is_implicated_in) | |
| Disease | central corneal thickness | 9.47e-05 | 309 | 44 | 5 | EFO_0005213 | |
| Disease | albuminuria | 3.77e-04 | 94 | 44 | 3 | EFO_0004285 | |
| Disease | chronic obstructive pulmonary disease | 5.22e-04 | 688 | 44 | 6 | EFO_0000341 | |
| Disease | Colorectal Carcinoma | 5.80e-04 | 702 | 44 | 6 | C0009402 | |
| Disease | corneal topography | 5.82e-04 | 109 | 44 | 3 | EFO_0004345 | |
| Disease | Nephrotic Syndrome | 7.45e-04 | 27 | 44 | 2 | C0027726 | |
| Disease | obsolete aging | 7.89e-04 | 279 | 44 | 4 | GO_0007568 | |
| Disease | intraocular pressure measurement | 9.34e-04 | 509 | 44 | 5 | EFO_0004695 | |
| Disease | cutaneous squamous cell carcinoma | 1.11e-03 | 33 | 44 | 2 | EFO_1001927 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YAPFVGGTGPGLPRG | 2196 | Q9P281 | |
| PFVPFSGGGQRLGGP | 241 | Q9BZE9 | |
| GITGPQGAPGFPGAV | 181 | Q14031 | |
| SVGFVGFPGIPGLPG | 901 | Q14031 | |
| LGSPGLIGPKGFPGF | 1156 | Q14031 | |
| FVGGLVGGPPGLAVG | 51 | Q9NSK7 | |
| NFGPNFRGPGPGGIV | 1926 | Q8TDI0 | |
| EQGFPGLPGTLGYPG | 131 | Q01955 | |
| GLPGTLGYPGIPGAA | 136 | Q01955 | |
| HGLPGYLGSPGIPGV | 451 | Q01955 | |
| LVAFGGGGGAPFPQP | 326 | Q9C0J9 | |
| GVLFAPFGRAGAPGP | 536 | Q13202 | |
| PPGSTGLRGFIGFPG | 1031 | P53420 | |
| FIGDPGIPALYGGPP | 411 | P08572 | |
| PGVAGPPGITGFPGF | 1051 | P08572 | |
| PPGITGFPGFIGSRG | 1056 | P08572 | |
| GFPGITGVTGVQGPP | 1131 | P08572 | |
| GPPFVGPVGFGPGDR | 116 | Q9BTD8 | |
| QEPGFLPLSGSFGPG | 1686 | Q96PE2 | |
| GFGGPGFPVCPPGGI | 121 | P48668 | |
| FPQTFAGPIIGPGGT | 746 | Q9Y5V3 | |
| GFGGPGFPVCPPGGI | 121 | P02538 | |
| VKPNGPGFTGGGFPL | 851 | Q5T655 | |
| GFGGPGFPVCPPGGI | 126 | P13647 | |
| GFGGPGFPVCPPGGI | 121 | P04259 | |
| RQGPKGSLGFPGFPG | 806 | P13942 | |
| GPLEAGLFFPGSGGV | 3516 | O15230 | |
| GSFPFLPGGPPVGAE | 246 | Q02080 | |
| GDFALLPGGPPGVFF | 476 | Q6V1P9 | |
| LPGGPPGVFFLCVEG | 481 | Q6V1P9 | |
| GDAYIPGGPLTVPGG | 26 | O00110 | |
| FVFPGGPGGLGSKPS | 426 | P08648 | |
| GFPGTPGLPGFKGIR | 166 | P08123 | |
| VLALGFPFGSGPPEG | 126 | Q9UIM3 | |
| GGFAPGTEPFPGLFP | 656 | Q9C0K0 | |
| YGAPGVAGLGVPGSP | 486 | Q9BQW3 | |
| PITNGFAGVVPFPGG | 316 | Q8N6W0 | |
| RGFPGSPGFPGLQGP | 131 | P29400 | |
| EGPIGFPGPKGVPGF | 291 | P12110 | |
| PFIRTGLLGFVGPGG | 771 | Q9Y2E4 | |
| VGLPGVGKPGVTGFP | 266 | P27658 | |
| PGLQGFPGKPGFLGE | 431 | P27658 | |
| PGRQGPKGSIGFPGF | 876 | P20908 | |
| LGLPGLPGAPGVVGF | 2391 | Q02388 | |
| LPGAPGVVGFPGQTG | 2396 | Q02388 | |
| GTRGFPGFPGPIGLD | 166 | Q5TAT6 | |
| YGPGGTGFIPIPGGN | 451 | P35556 | |
| TGFIPIPGGNGFSPG | 456 | P35556 | |
| GAIPGGVPGGVFYPG | 31 | P15502 | |
| VPGVGLPGVYPGGVL | 141 | P15502 | |
| PGGVLPGARFPGVGV | 151 | P15502 | |
| PGVGVLPGVPTGAGV | 161 | P15502 | |
| GVGGAFAGIPGVGPF | 181 | P15502 | |
| FAGIPGVGPFGGPQP | 186 | P15502 | |
| VGGIPTYGVGAGGFP | 391 | P15502 | |
| PGVGVAPGVGLAPGV | 516 | P15502 | |
| ARPGFGLSPIFPGGA | 761 | P15502 | |
| SLGPLGSGGFVPFGF | 236 | Q8WY07 | |
| GGRGQIFFPPLEAPG | 41 | Q9Y2M2 | |
| IPGFAGNIGSPGYPG | 586 | Q17RW2 | |
| GLTGFQGFPGPKGPE | 1396 | Q17RW2 | |
| PGLNTPEFFLGGGPG | 821 | Q7RTX0 | |
| SGSGGGFGPPFLPDV | 31 | Q9H832 | |
| RGGGPVFPAPVVGSG | 236 | O15209 | |
| KTPVPFGGPLVGGTF | 196 | Q8TDC0 | |
| FGGPLVGGTFPRPGT | 201 | Q8TDC0 |